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The first orthotopic liver transplantation was periormed 
In Denver In 1963.1 It was an unsuccessiul attempt. as were 
the next seven transplants periormed in Denver. Boston. 
and Paris. The iirst long-term survival aiter liver transplan-
tation was 10 1967.2 The late 1960s and 19705 saw very 
slow progress in this field. with an overall I·year patient 
survival of only 35%. as well as frequent and disabling 
complications. J 
Several maior advances In the earlv 1980s-the introduc· 
tion of cyclosporine.· ... the progress in donor surgery; and 
l)rgan preservation." and the reiinement of the surgical tech· 
illque'-Ied to greatlv improved results. lu As a consequence. 
there was an exponential increase in the number 01 liver 
transplantatIOns periormed-In 1988. a total of 511 were 
carried out at the Universitv of Pittsburgh alone. Over 40 
centers In the United States are currently engaged in liver 
transplantatIOn. and several of them periorm more than 100 
per year. 
INDICATIONS FOR ORTHOTOPIC 
LIVER TRANSPLANTATION IN ADULTS 
Relotive 
Indicotion Result Recurrence 
Chronic active 
hepatitis (viral) 
C (non-A/non-B) Good Low , 
B Fair-ta-good High' 
A Good Low· 
Primary biliary cirrhosis Very good :-.101 
Primary sclerosing Very good :-.101 
cholangitis 
Laennecs cirrhosis Good Low' 
Fulminant hepalltis Fair Low II 
Neoplasms Poor High" 
Metabolic disorders Excellent :-.10 
Autoimmune hepatitis Good Low 
Budd-Chiari syndrome Fair-ta-good Medium" 
Trauma Excellent ~o 
'Clur evidence oi recurrence Ilclon«. With the exceotlon 01 very lew 
(aK!. 'VirtuAlly 1009& hlstO!OQlc recurnnce: With. clinical recurrence. 
Jurltlon to end·staae disuse unknown. 4Vuy lew durly documented 
c.ut:J Oi chroniC lClive he~lItls type A. INo evtdence 01 rtturrence In our 
~erlel" Postullted by Cllne 10 one use. "'Recurrence rlpldly lethal if the 
patrent resumes drui.kln$l; mOlt p,llIentJ do not. "On Iv for ht~utll B: 
vrry tllih s.eroPOSIUvll)', but low cliniCAl recurrrnce ..• Apudomu lnd 
flbrolamclilr hepatomas rave lower rrcurrence.lt leut In the short 
term. "Recurrence V1rtu.lJiy the rlJlr. unless the J)ltlent IS undergoll\l 
lonl-term Intlcoaaululon. 
Figure 7.1 
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INDICATIONS 
The National Institutes oi Health Consensus Conference oi 
1983 established orthotopic liver transplantatIOn as the 
therapeutic modality of choice ior certain end-stage liver 
diseases.' 1 and the indications continue to increase. As more 
experience has accumulated. the advantages of liver trans-
plantation 10 terms of survival and quality of life when com-
pared with existing therapeutic mooalities have become 
increasmgly evident. There is no accurate estimate of the 
patients in the U.S. who need liver replacement every year, 
but their number probably is in excess 01 50/l.000,000 inhab· 
itants. Sadly, the need for organ replacement far outstnps 
both the number oi available donors and transplant teams. 
Adults 
The indications ior orthotopIC liver transplantation 10 the 
adult popuiation. in decreasmg order 01 irequency, are listed 
LIVER TRANSPLANTATION 
INDICATIONS IN CHILDREN 
Relative 
Indication Result Recurrence 
Biliary atresia or Good ~o 
hypoplasia 
Metabolic disorders' Excellent :-.10 
Neonatal hepatitis Good to ~o 
excellent 
Fulminant hepatitis Fair to good Low' 
Chronic active Good Low 
hepatitis 
Neoplasms Fair to poor High 
Familial intrahepatic Excellent :-.10 
cholestasis 
" (a.-!-.lnutrypsin d.ehclencv. tyrosinemia. Atycogen storaQe dlseue type (v. famdtal hypercholesterolemia. etc. I. 'Same I.J 10 adults: tOXIC hepautls 
[(speciAlly drug-mduced) much more frequent. 
Figure 7.2 
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in Fig. 7.1. Some of the indications have increased in 
frequency over the last few years (chronic active hepatitis 
and Laennec's cirrhosis particularly), while others have 
decreased. either because less cases are available (primary 
biliary cirrhosis is the pnme example) or because of poor 
results (tumors!. Our group has been particularly aggressive 
With transplantation for unorthodox or unusual indications. 
a trend that has been very helpful in breaking new ground in 
areas heretofore unexplored. 
Children 
The indications for liver replacement in children I Fig. 7.2) 
are quite different from those in the adult population. Con-
genital and/or metabolic disorders form the bulk of the 
indications. 
DISEASE-SPECIFIC INDICATIONS 
Transplantation Required 
Before Conditions Develop 
Chronic 
Massive variceal bleeding 
Irreversible hepatorenal syndrome 
Catabolic state incompatible with 
surgical survival 
Severe hepatic osteodystrophy 
Bilirubin 20 mg/dl 
Albumin 1.8 g/dl 
Poorly controlled coagulopathy 
Cardiovascular instability with anasarca. 
ascites. and pleural effusion 
Fulminant 
Grade IV coma 
Cardiovascular instability 
Intractable coagulopathy 
Hepatorenal syndrome 
Septic complications 
Fulminant form of Wilson's disease 
Subacute 
Bilirubin 25 mg/dl 
Variceal bleeding 
Hepatic coma 
Hepatorenal syndrome 
Septic complications 
Severe coagulopathy 
Figure 7.3 
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Early Transplantation Required 
Refractory asciteslhepatorenal syndrome 
Recurrent variceal hemorrhage 
Recurrent spontaneous bacterial 
peritonitis 
Hepatic osteodystrophy 
Intractable pruritus 
Conditions that Delay Transplantation 
Infection 
Bacterial 
Viral 
Fungal 
Mycobacterial 
Ischemic heart disease 
Cardiomyopathy 
Acute pulmonary disease 
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CONTRAINDICATIONS 
Fil(ure I . .tlists the absolute amI relative contramdlcatlOns. 
In addition. It indicates the conaitions that require earlier 
transplantatIOn and those that delav It. 
PREOPERATIVE 
EVALUATION OF THE RECIPIENT 
The evaluatIOn 01 the liver transplant canal date Involves 
r~lativelv stral~htiorward nOninvaSive and InvaSive tests 
Iltended to define the precise lliagnosis. stal(e 01 the disease. 
i'ro~nosls. speed or expected proJ;!resslon lor the disease. ana 
:he result exoected trom transplantatIOn. The presence ot 
nJII~nanc\" has to be rUled out. PerUc ulcer disease snould 
;,e excluded. This workup usual Iv can be pertormed on 
.111 outnatlent baSIS. thus reLluclng the costs 01 the initial 
(valuation. 
rerentlal. platelet count. prothrombin time. partial throm-
hoplastln time. total serum protein/albumin. blood urea 
Illtrogen. creatlnine. serum electrolytes. total and direct 
hilirubln. serum ~Iutamlc-oxalacetlc transaminase. serum 
glutamic-pyruvIc transammase. gamma-~Iutamyl trans-
krase. alkaline phosphatase. lactic dehvdrogenase. [V\~' •. uric 
acai. fastmg NH. level. hepatitis A and B screen. and delta 
ugent screen. 
LABORATORY TESTS AT THE TRANSPLANT CENTER. 
Illood sugar. La'-. amvlase. serum protem electrorhoresis. 
cholesterol. antiViral liters Icvtomegalovlrus. Epsteln-I:)arr 
;,nd herpes Simplex vlrUSI. panel reactive antibody. and tissue 
t\'pm~ tests. 
OTHERTESTS. T\\'elve-l~aJ el~ctrocardJOl!ram. urine anal-
\\15 and clean catch unne lor culture and sensltlvitv. stool tor 
\nv tests that are part ot a researcn protocol are IinJncetl (ulture. ova. anLi parasites lespcclallv Lit/raUl and Stronay-
;"v grant monev to aVOid uvercnarl!lng the oatl~nt or the IlIidesl. and stool lor occult blood .' .L 
r1surance carner. 
RADIOGRAPHIC STUDIES. (hest x-ray. aodommai com-
'"ABORATORY TESTS. These tests. patormed I to 2 weeks rutenzed tomographv scan with liver voiume estimatIOn. 
prior to evaluation. comprISe complete hlood count With dli- ;,nil abdominal liver ultrasound With Doppler evaluatIOn 
LIVER TRANSPLANTATION CONTRAINDICATIONS 
Absolute 
SepsIs outSide the hepatobiliary system 
"1etastatlc disease irom non hepatic cancer with the exception oi 
apudomas In which resection 01 the prtmary tumor In 
conjunctIOn With transplantation oi the liver can be curative 
~letastatlc hepatobiliary mah$!nancy 
Active alcoholic disease or dru$! abuse 
Severe hvpoxemia secondary to n~ht to left shunt 
Inability oi the pattent and/or iamlly to understand the 
implications oi and the commitment to liver transplantation 
and lirelon$! ImmunosuppreSSIOn need 
Advanced cardiopulmonary disease 
Symptomatic AIDS 
Figure 7.4 
PATIENT CLASSIFICATION 
Status 
11 
III 
IV 
Description 
.\t home. fully active 
At home. disabled 
In hospital. rei!ular bed 
In intenSive care Unit 
Relative 
~onmetastatlc hepatobiliary mali$!nancy 
Chronic hepatttls B 
ExtenSive portal vein thrombosis 
Extensive prevIous abdominal surgery 
Severe alcoholic disease 
Asymptomatic HIV-l-posltlve patients 
Severe renal failure 
Age over ti5 {physiologiC a$!e more Important than 
chronolo$!lc a$!el 
eNOS' status In intenSive care unit. usmg respirator. moribund 
Tnited Nttwork or OrA-an Shann". 
Figure 7.5 
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of the patency and tlow direction ot the hepatic vessels. 
Optional: celiac and superior mesenteric an~lO~raphv I to 
study the portal Ilow and patency I. coronary arteno~ram. 
PSYCHOLOGIC STUDIES. Complete psvcholo~lc proiile. 
evaluation bv the sOCIal worker. 
OPTIONAL STU DIES. .\onmvasive-~ I~ctroencephalo­
~ram. MUGA (radionucl1de calculation or electIOn tractlOnl. 
thallium stress test. pulmonarv function tests. peripheral 
artenal Doppler studies. 
Invasive-esopha~o~astroduodenoscopv with or without 
biopsy. cOlonoscopy. anll.lo~rams. neeole liver blopsv. endo-
SCOPIC retro~rade choledochopancreato~raphy. percutaneous 
trans hepatic cholan~lOll.ram with or without biliary duct 
catheterization and brush bIOpSies. anu exploratorv laparo-
tomv (In the cancer cases. to luentltv the presence and/or 
extent ot extrahepatiC spreaOI. 
I)nce all the resuits are avarlable. the evaluatIOn commit-
tee. composed of surll.eons. ll.astroenterololl.lsts. anesthesi-
1)IO~lstS. psychoIOl.!lsts. SOCial workers. and transplant nurse 
coordinators. meets to discuss the patients ano decide on 
their canoidacv. If a patient IS accepted. he or she IS placed on 
the transplant candidate list. A status I Fi~. i.51 is aSSigned 
Jccordin~ to the patlenfs present cOnlJltion. expected course 
tlf the disease. and ur~ency. 
PREOPERATIVE 
CARE AND MANAGEMENT 
The iunoamental ~oal dunn~ the preoperative penod. be it a 
lew uays or a tew Years. IS to maintain the patient In the best 
pOSSible condition. This means that the compiicatlOns oi 
end-stage liver disease have to be aVOided carelully and. ii 
they occur. treated early and aj!,gresslveiy. 
'-:utritlonal status should be maintained using a diet rela-
tIvely low In protem to aVOid encephalopathv and low m 
su~ar to avoid hypeq~lycemla. Salt and tlUid restrICtion may 
be necessarv as well. A rather hl~h content ot fat In the diet 
will ensure an adequate caloric intake. i>lultiyitamln prepara-
tions and vitamin K, also should be administered. particu-
larly to patlents With advanced degrees O( liver inSUfficiency. 
The patient should exercise as much as the condition 
allows to maintain ~ood muscular tone. Smokinl! should be 
stronll.ly discoura~ed and alcohol prohibited. All dru~s must 
he taken cautIOusly. espeCIally narcotics. because their 
delayed liver metabolism may easily lead to encephalopathy. 
I'recaullons must be taken to prevent InfectIOns. If bac-
terial iniections occur. Immediate antibIOtic therapy must 
he started. at Imt With a second- or third-generation ceph-
;Jiosponn and then. once the culture and sensltlyitv results 
.1re ayaliable. With a specliic agent. Pan-cUlturin~ oi the 
patient must be done. Includinj!, para- and thoracentesIs if 
ascites or effUSions are present. 
It IS also Important to try to prevent encephalopathy. 
Besides diet control. thiS is achieved bv regular administra-
tion or lactulose. Periodic measurement of the blood ammo-
IlIa level may be needed to identify subliminal. unreco~mzed 
encephalopathy. If it does occur. vIgorous treatment With 
lactulose and orallv administered neomYCin IS necessarv. 
Sudden onset oi encephalopathy In a preVIOusly stable 
patient should raise the pOSSibility oi sepsIs. because thiS IS 
J. irequent cause ot hepatic decompensation. second onlv 
to variceal hemorrhage. As a rule. suificient lactulose IS 
~Iven to proouce diarrhea. after whIch the dose IS reduced 
to the pOint where the patient has two to four soit bowel 
movements a day. In the patient With encephalopathy. there 
should be a low threshold for intubating the patient to pro-
tect the aIrway irom aspIration oi gastnc contents. 
.\scltes anu pleural eliusion shOUld be controlled with 
(luld/sodium restriction anu diuretics-lOop ana potasslum-
sparing agents are particularly useful for this purpose. 
However. exceSSlye dehydration should be aVOided. because 
It can lead to renal failure. t>lasslye ascites. which reduces 
Jiaphra~matlc excursIOn and causes pulmonary Insulii-
(lency. may require multiple paracenteses tor alleyiation oi 
symptoms. This procedure must be perlormed with the 
utmost caution. because It causes loss oi proteins and can 
predispose to renal failure. BeSides the obVIOUS discomfort to 
the patient. maSSlye ascItes. particularly If of sudden onset. 
should alert the phYSICian to the pOSSibility oi portal vein 
thrombosis. This must be immediately investigated with 
Doppler ultrasound or nuclear magnetIC resonance examina-
tion and. if the results are inconclUSIve. even an~lography. 
Upper gastrointestinal bleeding must be prevented with 
the use of antacids to reduce gastnc irntatlon. Although of 
unproven value. propranolol is frequent Iv used for preven-
tion of yanceal hemorrha~e. Sclerotherapy to treat variceal 
bleeding mav be mdlcated. ProphylaCtiC sclerotherapy IS not 
warranted in a patient who has not bled and may be aSSOCI' 
ated with lethal complicatIOns. 
Last. but not least. It is crucial that abdominal operations 
be aVOided at almost all costs In patients known to be trans-
plantation candidates. C:ven apparently tnvlal procedures 
like cholecystectomv or open liver blopsv can cause exten-
sive and highly vascular adheSions. and will enormous Iv 
complicate the recipient hepatectomy. Uther procedures to 
be ayolded include common and/or hepatiC duct explora-
tion. gastnc and duodenal sur~ery. liver resection. and even 
pentoneo)ugular shunts. Abdominal surgery In the liver 
transplant candidate can only be justliied for lifesaYIn~ 
procedures. Nonoperatlve intervention t even oi the InYa-
SlVe type. like PTe and needle liver bIOpsy I IS the method 01 
chOice in this group oi pattents. Repeated episodes of sponta-
neous bacterial pentonltls also can cause senous adheSIOns. 
ANESTHESIA IN 
LIVER TRANSPLANTATION 
AnestheSia ior liver transplantation IS compiex and challen~­
ing. iS - I; The pauent WIth end-staj!,e Ilver disease frequently 
IS In a state simllar to that found In sepuc shock. namely. one 
of high cardiac output and low peripheral vascular resls-
tance. l " Moreover. the coagulation parameters may be grossly 
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abnormal (elevated prothrombin time and activated partial 
thromboplastin time. decreased platelets and fibrinogen. 
etc.I. 19 To complicate the matter. there may be some degree 
of renal failure. as well as hypoalbuminemia. 18 Preoperative 
anesthesiology consultation gives the anesthesia team an 
opportunity to meet the patient and go over any unusual 
problems. 
Blood loss during liver transplantation occasionally can be 
massive. The anhepatic phase is particularly delicate and 
used to be a moment of crisis before the introduction of the 
venovenous bypass. The unciamping and revascularization of 
the new liver can lead to extreme hyperkalemla. 18 Other 
products of the intestinal anaerobic metabolism and air pre-
viously entrapped in the hepatic microcirculation are major 
potential dangers. Finally. after reperiusion. there may be 
a period of fibrinolysis. 18- 2o which requires aggressive and 
Swon·Gonz catheter 
Figure 7.6 
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sophisticated intervention to achieve reversal and normal-
ization of the clotting parameters. The large amount of 
administered fluid. particularly during the anhepatic phase. 
may lead to pulmonary edema and ventilatory difficulty. IS 
Involvement of the anesthesia team is constant during the 
procedure. and difficult situations can demand the participa-
tion of several people rotatmg in groups of two to four. 
Positioning 
As shown in Fig. 7.6. the patient is placed in the supine posi-
tion on the operative table. with both arms abducted. A Foley 
catheter and a rectal temperature probe are placed after 
induction of anesthesia. The feet are mdividually wrapped in 
plastic foam. then wrapped together. and a soft pillow is put 
under the calves. 
Blood flow introducer set 
far rapid infusion system 
Monitoring 
Continuous mOnitoring oi many different parameters IS used 
Jurmg liver transplantatIon IFig. 7.il. 
The several lines required IFig. 7.6) inciude: 
1. Two radial arterIal lines lor one radial and one iem-
orall. The Allen test should be performed before these 
are placed. One line IS used for pressure mOnitorIng 
and the other for blood drawmg. 
2. One large-bore perIpheral intravenous catheter In the 
antecubital vein of the arm oPPosite to the sIde of the 
bypass. 
PARAMETERS 
FOLLOWED DURING SURGERY 
Parameters Frequency 
ECG C onttnuous 
Radial artenal pressure 
Central venous pressure 
Pulmonary artenal pressure 
On-line mIxed-venous 
oxygen saturatIOn 
Temperature-esophalleal. 
rectal 
Crine output Hourlv or more oiten 
Urine speCIfic Ilravltv Ii needed 
Artenal blood gas 
Acid-base status 
Hemoglobin 
Hematocnt 
Serum Na'. K'. Ca--. 
blood sugar 
Cardiac output I Co) 
Prothrombin time Every 2 to 4 hours or 
Activated partIal more oiten If necessary 
thromboplastin time 
Platelet count 
Thrombin time. rephlase 
time. plasma clot lYSIS 
time. levels of factors I. 
II. and VIII. fibrin split 
products. ethanoillel 
test. euglobin lysis time 
Thromboelastogram Frequentlv 
Figure 7.7 
3. One large-bore external or internal Jugular catheter I to 
serve as access for the rapid infusion system I. 
4. A Swan-Ganz catheter capable oi on-line mIxed-venous 
oximetry. This catheter usually is inserted through the 
nght internal jugular vein. 
Preparation 
Figure 7.8 shows the equipment necessary during the trans-
plant operation. Figure 7.9 lists the medIcations avaIlable for 
ImmedIate use. 
ANESTHESIA EQUIPMENT 
Anesthesia gas machtne with compressed air supply 
Ventilator 
Gas humIdifier 
Vital signs momtor and recorder Imultiple channeD 
Cardiac output momtor Ibased on thermodilution 
technique) 
On-line mixed-venous oxygen saturation oj hemoglobin 
~ass spectrometer tattached to the aIrway. to measure 
end-tidal gas tensIOns) 
Thromboelastography tat least twO) 
Rapid infusion system 
Blood pump with warmer 
Autotransfusion machine loptionall 
Cardiac defibrillator Iwith external and internal pads) 
Warmin!! blanket 
Extra supply cart 
Figure 7.8 
MEDICATIONS 
AVAILABLE FOR IMMEDIATE USE 
Ampicillin 
Atropine 
Cefotaxime 
Cyc!osporine 
Dextrose 50% 
DopamIne infusion set 
D-tubocurarine 
Ephednne 
Epinephrine 
Fentanyl 
"PolymYXin S~BacltrlCln·NtomYCln. 
Figure 7.9 
Insulin 
Ketamine 
Lidocaine 
Lorazepam 
Methylprednisolone 
Neosponn' ointment' 
Pancuronlum 
Sodium bicorbonote 
Succinylcholine 
Thiopental 
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~lost patients undergoIng liver transplantation todav 
require less than 10 transfusions. However. In diificult cases 
land these sometimes are not recognized in advancel. the 
rapid iniusion system. capable oi delivenng 2 to :l liters/mIn 
ili warmed blood. mav be lifesavlng.,1 The warmIng blan-
ket. multichannel monltorJrccorder. and thromboelasto-
~raph should be In place routinely. The blood hanK must be 
~n a pOSitIOn to supply almost unlimited amounts or hlood 
,lOd clottIng products on verv short notice. The laboratorv 
llust be eqUipped to orovlde immediate results anI' time. day 
"r night. 
\rter posltlonlm" Iq,lht prcanesthesla IS allmlnlstered. 
fhis step can he omitted In the encephalopathlc patient. The 
rotentlal pressure POInts should be wei Inadded and the r~CG 
electrodes secured on the patient's back With tape. 
Intraoperative Anesthesia Management 
INDUCTION 
\lost patients In relatlvelv i.!ood conllition tolerate InLiuc· 
tlon well. Because g<lstnc emptYing IS Licla\'eLi 10 patients 
\11th end-stage lll'er disease. the\' are all consloereLi to have 
J rull stomach. Consequent I\'. preoxvgenatlon rolloweLi bv 
rapid-sequence InLiuctlOn usuailv are performed." KetamIne 
"r thIOpental anLi succInvlcholIne or atracunum I In case or 
IwperKalemlal are common I\' useLi. \'entilatlon IS accom· 
pilshed With 10 to Li ml·ki.!' t" achieve an end-tlLial CO. at.:\ 
til .:\.5':" or a Pa,,, ul.l5 to.:\11 mm Hi.!. The FlO. IS ;)iI to 70",1 
;Ind the posltll'e end-explratorv pressure IS 5. \itrous oXILie 
IS not used. because It causes IntestInal LilstenslOn ami can 
!'lcrease the size Of air emboli." botlurane IS the anesthetiC 
nost olten usell.-.\ narcotic IS rrequentlv useO as the pn-
:narv agent or tOl\dher 1\'lth an Inhalatory prlmarv agent: a 
sedatll'e such as lorazepam IS added. Either pancuronlum. 
metacurrne. or atracunum can be used. The iact that the\' 
~an be "washed oul' uue to lan;!e blood losses IS less Impor-
tJnt for these ilpopnillc agents." 
MAINTENANCE OF A PHYSIOLOGIC STATE 
There are three basic stages In the liver transplant oneratlon. 
Stage I occurs dunng reCIpient hepatectomY. stage II is the 
,mhepatlc phase. ano stage III IS the reperruslon stage. 
STAGE I (RECIPIENT HEPATECTOMY) l"i.lrdiol'asculi.lr 
,hanoes Inclulle hH~h cardiac output. Blood loss mal' C<luse 
11I·povolemla. wIllch IS treated by volume renlacement and 
admInIstration or CaCI, and dopamine. c"/uttino usuallv is 
poor. although It can be r,lIriv adequate In patients who are 
Itss Sick or who have cancer. Coagulation nroducts are 
"JmInlstered as neelled to correct thiS conLlltlon. The put· 
rnonaru IUnctum usuailv IS allequate. Fluids and dectrolutes 
"nen are iost In large amounts. anll the and hi.lse status 
expenences consHlerable shiltS. Lorrectlve measures must 
he taken. The bodu tem/Jerature slowiv decreases. as a con-
'cquence or the open abdomen and posslhle hlood Inss. 
I\'armell blood and warmIng blankets are used. 
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STAGE II (ANHEPATIC STAGE). Ci.lrdiovascular chanoes. 
II there IS no bypass. are characterrzed hI' low venous return. 
hij!h blood loss due to portal hypertensIOn. and low renal 
illnctlOn. These changes are treated With volume replace-
ment. although With partial success. Ii there is bypass. the 
changes are less pronouncea. hut adequate hlood volume 
must be ensured. Poor clot/ino may worsen. The treatment 
is Identical to that instituted during stage!. although over-
correction should be a\'olded to prevent thromhoembolism. 
The puimonaru (unction experrences no maJOr changes. 
L'lsses or f7uids and electro/utes. ano aCid hase shifts can ne 
clInslderable. Replacement IS necessarv. The K - level must 
be kept as low as practical to prevent postreperruslon hvper-
kalemla. The bod,u temperature cnanges are IdentIcal to 
those m stage I and should be Identlcalil' treated. 
STAGE III (REPERFUSIONI The cardlOl'Oscular chanoes 
freQuentlv include h\,potenslon. nradvcarola. and even elec· 
tromechanlcal Jissoclatlon. all due to release or high K' 
.lOd catabolic product tluid irom the liver and bowel. Treat-
ment consIsts olvolume replacement. CaCI ' . .ttropme. CPl' 
nenhrIne. dc. There IS !",ulmonarv h\'pertenslOn ano low 
mixed-venous oxygen saturation. The pwmonaru func/lOn 
Olav he threatened bv eLiema. The treatment. bl' wav or POSI-
til'e end·explratorv pressure and mcrease m mmute volume. 
" extremel\' Jiliicult. It !1osslhle. Ill!lLi InfUSion should 
he Liecreased. l~e~ardlOg flu{(is . .:i!!ctro/utes and the aCid 
hose. hvperkalemla. hl'pokalemlJ . .tCIL10SIS. and tluid losses 
.Ire common. Earll' and dl'namlc treatment IS necessarv. 
l'lott/na Improves. although mllial nhrmolvsls mal' occur. 
\Jmmlstratlon or E-ammOCann)l(: aClll anll coal!,ulatlon rroll· 
IIClS may be necessarv. /3oJu temperature: nl'pothermla IS 
\'efV common. Energetic rcwarmmg-Illcludmi.! "core Im-
~atlOn With verI' warm fluid-IS requlrell. 
CONCLUSION OF THE OPERATION 
111 most cases. II the operation has been successful and the 
111'er IS lIll!,lJOO ~ualit\'. the natlent s CI,l1ultlOn contInues 
to Improve and stabilize. The lactate lel'el decreases and 
the coagulation narameters and urine output Improve. fhe 
puimonarv iunctlOn. pulmonarv arterv rressures. central 
I'enous rressure. and other parameters normalize. With verI' 
hnei operatIOns 1.:\ hours or lessi. the patients can even be 
l,\tubated on the operative table at the end of the proceaure. 
Pediatric Anesthesia 
This area has been ampiv descnhed', ;1I11l IS essentlallv simi· 
br to auult anestheSia. :\ notable duference IS the high toler· 
.mce that children nave to venous cross clampmi.!. Because It 
h \'ery InconveOient or ImpOSSible to use venovenous b\'pass 
III patients wt'lgnlni.! less than 25 lJr .ill I'ounos. this is a great 
;Idvantage. Blood loss must be kept to a mlOlmllm. as the 
J'eolatrlc total blood volume IS so much smaller. Loa>lulatlOn 
I'mducts must be a\'OIded as mucn as pOSSible. because their 
JdmlOistratlon can nreOlsnose to hepatic arterY thromoosls.-" 
Retransp/antation 
For patients With prlmarv nontunctlon or acute re_lection. 
especially if complicated by multiple orlaan tallure. the man-
agement is similar to that used In iulmlnant hepatic iailure. 
On the other hand. patients retranspianted for chronic rejec-
tion or technical problems are much more stable ana. except 
for pOSSible blood loss irom extensive adhesIOns. their man-
agement can be relatlvelv Simple. 
TECHNIQUE OF 
LIVER TRANSPLANTATION 
The donor hepatectomv IS technical Iv simpler than the recip-
i~nt operation. but neither procedure leaves any room tor 
aror. Traditionallv. a liver transplant surlalcal trainee goes 
first throulah the steps oi masterln\! the donor operation 
before tacklinla the compleXities ot the recIpient nrocedure. 
_-\dditional details ot the donor operatIOn are a\'adable in 
Chapter 3. 
THE DONOR 
Selection 
There are no absolute selection criteria. but some ialrlv 
constant laulIJe lines are iollowed. The HIV-I ana hepatitis 
screemnla must be negative. In addition. tissue typing ot 
the donor as well as cytomelaalovlrus and Epstein-Barr 
\'irus titers are routlnelv checked. Donor alae can ranlae trom 
neonatal to over tiO Years. Optlmailv. the donor should be 
stable. Without slgnliicant Intraabdominal iniurles or pre-
VIOUS history oi liver or biliarv tract disease. ana reqUire 
minimal or no vasopressor support. However. none ot these 
criteria are absolutely essential. We accept a signliicant num-
ber oi orlaans relected bv other programs. Uur experience 
demonstrates that the iunctlon oi organs common Iv rated 
as "substandard" can be as laood as that ot "blue-ribbon" 
graits.'; -:" "epsis should be absent. although we nave occa-
sionallv used livers trom donors With positive bodv t1uid 
cultures Ii the source was obvious and extraabdomlnal. 
~taintenance ot the donor IS a compiex ana sopmsticated 
task and should be undertaken. Ii pOSSible. in an Intensive 
care Unit setting. under constant supervision. Poor care oi 
the donor Will most likelv compromise the quality oi the var-
IOUS organs. Une useiul step. particularly ior personnel 
involved in donor maintenance In a small hospital with min-
imal or no prevIOus experience. IS to enroll the help ot the 
local procurement agencv earlv on. The coordinators work-
ing ior such agencies have Invaluable adVice to otier ior these 
particular cases. 
The iluid and electrolvte balance must be maintained 
Within normal parameters. Frequentl\" brain dead patients 
have diabetes inSIpidus. Pitressln. espeCially the oli-vehicle 
subcutaneous type. should be aVOided as much as pOSSible. 
because It causes a decrease In splanchnic ilow ana vaso-
constrictIOn and can _Ieopardize the qualitv oi the graits. 
Consequentlv. close. mOnitoring ana replacement ot iree 
water will be necessary. It is cruCial that hypernatremia be 
aVOided. because It seems to conSiderably increase the inCI-
dence oi primarv noniunction oi the grait. On the other 
hand. overhydration must be aVOided as well. because high 
central venous pressure wtli result in swelling oi the liver 
and pOSSible poor iunction in the recipient later. Attention to 
rulmonarv toilet and maintenance oi good urinary output 
also are Important. 
The size oi the liver must be estimated. because size usu-
allv is a crucial limiting iactor In matching a donor organ to 
a specliic recipient. While a smaller liver can almost alwavs 
he put Into a large reCipient. a liver larger than normal i~r 
the reCipient may be verv diiiicuit or even impossible to 
transplant. The rule oi thumb IS that the liver represents 
approximate Iv 2.5% of the total bodv weight. The best clues 
are those obtained by examination ot the donor. For exam-
pie. an obese iemale donor Will have a much smaller liver 
than expected from her total weight. Because I cc oi liver 
tissue weighs roughly I g. the hepatiC volume can be easily 
~xtrapolated from its welJ.!ht. 
Besides hematOCrit and electrolvtes. the total and direct 
bilirubin. liver enzymes. prothrombin and partial thrombo-
rlastin times. blood urea nitrogen. and creatinine levels are 
measured. There are no strict upper limits set ior acceptabil-
Ity oi the liver. but. in the absence ot Intraabdominal injury 
and history oi prevIOus disease. two to three times normal 
are acceptable. The indirect bilirubin may be even higher Ii 
the patient has had a number ot transiusions. On the other 
hand. initially elevated enzymes leven 10 to IS times nor-
mal) aiter an Initial cardiac or respiratory arrest that sub-
s~quently decrease toward normal also are acceptable. par· 
ticularlv ii the liver looks normal at the time oi the harvest. 
This generally implies a liver that is soit. pinkish in color. 
and without obvious Injuries. producing normal-looking 
bile upon opening oi the bile duct. and which blanches rap-
idlv and evenly. while staving so it. once the cold periusion 
IS started. 
Surgical Technique-Donor Hepatectomy 
There are basicallv three techniques ior the donor hepatec· 
tomy: the so-called claSSIC. standard. and rapid periusion 
techniques. These Will be brietly descnbed here. Additional 
iniormatlOn is prOVided in Chapter 3. Special modifications 
must be used for harvesting oi livers trom extremely small 
pediatric donors. 
Generally speaking. aiter initial dissection oi the liver and 
heart and the begmnmg 01 cold pertuslOn. the heart IS the 
ii rst organ to be removed. then the I iver. and finally the 
kidneys. We stronltly emphasize that the kidneys need not 
be dissected as a preliminary step. This practice. still wide-
spread. is not helpful for the followintt reasons: 
1. The dissectIOn takes at least I hour. irequently 2. is 
usually qUite bloody (contrary to the commonly held 
opinion oi its supporters). and requires extensIve man-
ipulation oi the intestme. With resulting embarrass-
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ment of blood flow to the liver. It is fundamental for the 
renal procurement team to keep in mind that a com-
promised liver frequently will need to be replaced in the 
best of ci rcumstances or. at worst. prove to be lethal. 
2. This dissection. taken in the name of "identifying the 
anatomv." actuallv tends to increase the risk of renal 
vascular injury. especiallv to small lower polar arter-
Ies. because the exposure IS never perfect. Additionally. 
the skeletoOlzation of the arteries causes them to go 
Into spasm. conseQuentlv decreasing the amount of 
cold perfusion through the kidneys later. This is exactly 
contrary to what needs to be achieved. 
3. Once the liver IS out of the wav, the kidneys can be 
removed safely In about 5 minutes. to be then separ-
ated and cleaned leisurely and safely on the back table 
while kept in a basin filled With crushed ice and pres-
ervation solution, 
© 
Figure lorO 
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Thus. a better Quality of renal graft is pOSSible by deferring 
unnecessary preliminary dissection. In the final analysis. It 
gives a false sense of secunty to the surgeon. while in reality 
it Jeopardizes the organs one IS supposed to protect. 
CLASSIC AND STANDARD TECHNIQUES 
The clasSIC technique reQui res a rather elaborate dissection 
of the liver vasculature prIOr to cross clamping and cold 
perfusion. In the multiorgan donor. a long incision is made 
irom the jugular notch to the symphysis pubis. Two cannulas 
are put in place. one into the portal vein (by way of the 
splenic veinl and one into the lower abdominal aorta. just 
prOXimal to the iliac bifurcatIOn IFig, 7.101. After the place-
ment of the portal cannula. a slow precooling of the liver is 
begun. which continues until cross clamping. All the vas-
cular structures of the liver are carefully identified and 
isolated. This is a technique SUitable for the surgeon With 
artery. 
vet" 
somewhat less experience. because it permits the visualiza-
tion of the various hepatic vessels at leisure. It also permits 
the manipulation of the fluid balance for a more extended 
period of time. which may be useful if the fluid level is insuf-
ficient or excessive at the beginning. The main disadvantage 
is the extensive manipulation of the liver and danger of 
interference with its blood supply. 
The standard technique is similar. although the dissec-
tion is somewhat less extensive and the precooling phase is 
eliminated. This facilitates the interface with the heart recov-
ery teams. which frequently have objected to the precooling 
in the past on the grounds that lowering the temperature 
could cause arrhythmia. This technique is the one most com-
monly used. 
RAPID PERFUSION TECHNIQUE 
The rapid perfusion technique was initially used for liver 
recoverv from extremelv unstable donors. It consisted in 
cannulation of the distal' aorta only. without any other vas-
cular dissection. After cross clamping. the liver and kidneys 
Figure 7.IJ 
were perfused with cold lactate Ringer's solution. The liver 
perfusion was still dual. with a direct flush from the celiac 
axis and an indirect flush by way of the portal vein after 
passage of the perfusate through the mesenteric circulation 
from the superior mesenteric artery. The liver was then 
rapidly excised. without tieing any branches. A fair amount 
of extra tissue subsequently was removed on the back table. 
In the present rapid technique. a direct descendant of the 
method described above. the aorta is cannulated just above 
the iliac bifurcation. while the portal vein is cannulated via 
the inferior mesenteric vein (Fig. 7.11), without any prelimi-
nary dissection of the hepatic vasculature. Jo.J1 After cross 
clamping and cooling. the liver can be rapidly excised by 
ligating only the major collaterals and only on the hepatic 
side. The extra tissue removed with the liver can be then 
excised·on the back table. This technique has the following 
advantages: 
1. Preliminary dissection is kept to a minimum. reducing 
the risk of vascular injury and impairment of hepatic 
blood flow. 
mMMteric 
vein 
-+i ... -----Cannula 
in aorta 
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2. The collaterals of the hepatic vessels need only to be 
tied on the liver side. because the dissection is done in 
a blood-free rield after cross clamping. 
3. The techmque can be employed in stable and unstable 
donors equally well. 
4. The duration ot the entire procedure can be reduced to 
onlv 45 minutes to 1 hour. Preliminarv cannulation can 
he periormed simultaneously with cardiac dissection. 
The two majOr drawbacks of this technique are that the 
hrief time or preliminary work does not allow hemodvnamlc 
manipulatIOn or the donor m case the liver IS conk!ested. and 
,hat It requires more skill and anatomICal knowiedk!e because 
t he potential ror vascular mJury In an unramillar bloodless 
rield is increased. 
THE RECIPIENT 
Surgical Technique 
The recIpient operation IS a tour de Force or general surgery. 
with the hepatectomY orten being the most difficult step. The 
recipient operation IS an extreme Iv untor~ivin~ procedure. in 
which seemIn~ly tnvial errors can lead to disaster. A typical 
example is that ot the avulSIOn 01 a small posterior portal 
hranch leadin\! to either an air embolus Idurin~ the venove-
nous bypass phase) or uncontrollable hemorrha~e durin~ 
rutile attempts to place sutures m the face or promment por-
tal hvpertenslOn and friable vessels. 
Althoul1.h the hepatectomY technique has been standard-
~ "- Infenar \ 
 vena cava ~suprahepaltc, 
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ized to a large extent. no two transplants are exactly the 
same. Thus. a general plan of action must be established as 
soon as the abdomen IS entered. In most cases the hilar dis-
section should be perlormed first. In this way. the bypass is 
started and devascularization of the liver IS achieved earlv. 
with blood loss significantly reduced. Tedious hemostasis is 
mandatorv and all reasonable attempts should be made to 
achieve as much of it as possible belore Implantation of the 
homograft. On the other hand. it is counterproductive to 
spend an inordinate amount of time m periormin~ hemo-
stasis during the anhepatic phase. even With venovenous 
b\'pass. m unstable patients. In such cases. replacmg the liver 
rapidly With a good homogratt and unciampmg the venous 
compartment results in disappearance or the portal hvperten-
slon and production of fresh clottmg tactors bv the new liver. 
VENOVENOUS BYPASS 
We introduced venovenous bypass in 1983,l2-1~ Since then 
we have been usmg It routinely. and manv other liver trans-
plant groups have adopted it. However. Its acceptance is not 
universal. It consists in decompression of the inferior vena 
cava tvia the greater saphenous, femoral. and iliac vems) and 
portal circulation tby way of a portal cannula) usin~ hepar-
in-bonded Gott shunts, with return tlow mto the supenor 
vena cava through the aXlllarv vein trig. i.I21. Although 
I iver transplants can be perrormed without the bypass. we 
helieve that its advanta~es. listed below. make its use almost 
mandatory. 
000 
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1. In patIents with acute iailure or hepatic tumors not asso· 
clated with liver cirrhosis. the absence oi venous collat· 
erals mav lead to cardiovascular collapse durin~ cross 
clamping due to diminished venous return to the heart. 
2. The aVOIdance 01 portal clampIn~ prevents mesen· 
tenc stasIs and subsequent development and release 
'li anaerobic metabolism products Into the 'leneral 
circulation alter unciamplng. SimIlarly. dama~e to 
the kidnevs IS aVOided if the vena cava IS eliectively 
decompressed. 
3. Early bypass results In decompression oi the portal 
circulatIOn. which decreases o!ood loss. 
4. The lack oi portal hvpertenslon and vascular mstability 
JUring bypass permits a more unhurned operation. 
;Jllowing a more complete hemostasIs as well as the 
trainin~ 01 new surgeons. 
5. Finally. the venovenous bypass can be regarded as a 
saiety net. because II compilcatlons arise that require a 
lon~er anhepatlc phase. these can be dealt with eifec-
tively Without leopardlzing the patients life. 
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Figure 7.13 
Figure 7.15 
BILIARY RECONSTRUCTION 
We reconstruct the bile duct either bv means oi an end-
to-end choledochocholedochostomv over a T-tube or an 
end·to-side choledochojejunostomv ~Ith a Roux-en·Y loop 
over an internal stent. These techniques will be descnbed 
later. Other methods oi biliary reconstruction have been and 
still are used by other groups.>3 
PRELIMINARY PHASE 
The patient is placed on the operative table in a supine posi· 
tion. with both arms abducted (Fi~. 7.6\. The neck. chest. 
abdomen. upper thi~hs. and grom are prepped with organIc 
iodine solution and drapes are placed. leaving an extremelv 
wide field. We start the operatIOn bv perlormmg the axlilarv 
(Figs. 7.13. 7.14) and greater saphenous vein (Fig. 7.15) dis-
sections through appropriate inCISIOns. These usually are on 
the left side. although in retransplantations we use the 
untouched right side. Extreme care IS taken so as not to 
injure the brachial plexus that surrounds the axillary vein. At 
a later time. once the bypass has been removed. the axil-
Figure 7.14 
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lary vein. if single. is repaired with a fine Prolene' running 
suture: Ii double. the branch IS simply ligated. 
RECIPIENT HEPATECTOMY 
INCISION. A bilateral subcostal incision with a midline 
extension to the xiphoid is used. extending more on the right 
than on the left (Fig. 7.16A\' Alternately. a TIght hockey stick 
inCISion can be used (Fig. 7.16BI. In pediatric patients. 
an upper abdominal transverse inCision is the norm (Fig. 
7.16CI. The round ligament. irequentlv very bulky and 
containing large collaterals. IS divided between ties. Once 
the upper surface 01 the liver IS tree from the diaphragm. 
A B 
Figure 7.16 
Figure 7.17 
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a Rochard retractor is placed to retract the costal margins 
upwards and backwards (Fig. 7.17). The quality of the expo-
sure achieved with the Rochard obviates the need to extend 
the incision into the chest to expose the suprahepatic vena 
cava. During the last year. the first author has been using 
the Iron Intern" (Fig. 7.18). a table-mounted. self-retaining 
retractor that enables the surgeon to perform the liver trans-
plant procedure with only one assistant. thus reducing man-
power requirements by 50%.35 
EVALUATION. At this point. the situation is evaluated as 
far as the liver condition and presence of adhesions or other 
C 
Figure 7.18 
problems are concerned. and a plan of action is formulated. 
If no adhesions are present. the left tnangular and ialciform 
ligaments are divided with a cautery tFigs. 7.19.7.20), The 
gastrohepatic ligament can be divided now as well. usually 
between ties. especially if an aberrant left branch is present. 
HllAR DISSECTION. A detailed inspection and palpation 
of the hilum must now take place. If pOSSible. a linger should 
he passed completely around the hilum from behind to pal-
pate the portal vein for thrombosis tin which case It will feel 
like a hard cord) and from the right posterior margin ior an 
aberrant right branch (Fig. 7.21), 
The dissection is then started by first opening the pen-
toneum covering the hepatoduodenal ligament, either with 
the cautery or between ties. As opposed to the donor hepate-
ctomy. the recipient dissection takes place high in the hilum 
to preserve as much length as possible for the various struc-
tures that wi! I have to be used later for revascularization. 
~. 
Figure 7.20 
Figure 7.J9 
Figure 7.2J 
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Figure 7.22 shows the most important structures that have "peanut") will free the 5 to 6 cm of portal vein necessary for 
to be identified during the recipient"s hepatectomy. All the cannulation. 
structures that need to be divided will be doubly tied. The 
hepatic artery should be divided first. if possible. because CANNULATION. The axillary and greater saphenous 
this will reduce the subsequent blood loss (Fig. 7.23l. The veins are cannulated at this point IRumel clamps will keep 
cystic and common hepatic ducts are then divided between them in placet (Figs. 7.27. 7.28). The portal vein can now be 
ties /Figs. 7.24. 7.25). The portal vein usually can be identi- ligated or clamped high in the hilum (if the major branches 
fied at this point. All the areolar. lymphatic. and nerve tis- can be easily dissected. individual ligation should be per-
sues around the portal vein are sectioned between ties so formedl. transected. cannulated end-on with a Gott shunt. 
as to completely skeletonize it (Fig. 7.26l. Blunt proximal and tied in place with heavy silk or umbilical tape (Figs. 7.29. 
and distal dissection with a Kittner swab lalso known as a 7.30l. The cannulas are flushed with heparinized saline 
Figure 7.22 
Figure 7.23 Figure 7.24 
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Figure 7.25 Figure 7.26 
Figure 7.27 
Figure 7.29 
ORTHOTOPIC LIVER TRANSPLANTATION 7. 77 
solution 11.000 U/literl and interconnected. The bvpass can 
then be started. In adults. at least 1.500 cc/mIn should be 
tlbtamed. In children. the bypass usuallv can be used ior 
patients wel~hing 25 to 30 Ibs or more. Flows 01 500 cC/mm 
()r more are acceptable. 
COMPLETION OF HEPATECTOMY. The Intrahepatic 
vena cava can now be encircled and clamped (Fi~. 1.31l. The 
remainin~ part of the talclform li~ament. as weil as the 
medial aspect ot the right trlan~ular ligament. are divided. 
Figure 7.31 
Figure 7.33 
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The suprahepatic vena cava is encircled and then clamped 
I Figs. 7.32.7.331. The liver IS now removed. This can Dest be 
done by leavln~ at least the posterior wall of the retrohep-
abc vena cava In place I Fig. 1.3-lL In this manner the retro-
peritoneal structures. especlallv the rI~ht adrenal gland. wJlI 
not be injured. Also. the adrenal vein can be identified from 
within the caval lumen ana easilv tied (Fig. 7.34l. The liver 
also can be excised oif the retrohenatlc cava. leaVing the 
entire vessel in place (Fi~. 7.35l. This step is carried out bv 
dissecting trom lett to rI~ht under the caudate lobe. as 
Figure 7.32 
Figure 7.34 
Figure 7.35 
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shown in Figure 7.36. The advantage of this technique is that 
it allows the surgeon to fashion adequate caval cuffs under 
any clrcumstance.J6 
HEMOSTASIS. Once the liver is removed and the adrenal 
vein ligated. the "bare area" behind the liver IS oversutured 
with running Prolene sutures (this reperitonealization is 
excellent for hemostasis) (Fig. 7.35\. If the bleeding is not 
Significant. superficial cauterization with electrocautery or 
an argon beam coagulator is suificient (Fig. 7.37). Any other 
major bleeding area can be controlled at this time. when the 
absence of the liver ensures superb exposure. The recipient 
hepatic artery also can be dissected free at this time. 
FASHIONING THE CUFFS. The lower cuff can be easily 
fashioned by just trimming the redundant cut vessel. A care-
ful search for severed branches near the proposed anasto-
mosis site is necessary to prevent bleeding after unciamping. 
Common bile 
Figure 7.36 
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For the upper caval cuff. the openings of the individual 
major suprahepatic veins are interconnected (dotted lines in 
Figure 7.38Al. An ample common funnel is thus obtained 
(Fig. 7.38B). which subsequently can be trimmed to the appro-
priate length. The temptation to leave long cuffs must be 
resisted. because long vessels can kink and an acute Budd-
Chiari syndrome may occur later. 
IMPLANTATION (VENOUS ANASTOMOSES) 
The liver is brought into the wound for implantation. We 
usually perform the anastomoses in the following order: 
suprahepatic vena cava. infrahepatic vena cava. portal vein. 
After unciamping and revascularization oi portal flow. the 
artenal anastomosis is performed. Occasionally all four 
vascular anastomoses are completed prior to unciamping. 
The same technique is used In all venous anastomoses. One 
suture is placed at each corner of the vessel to be sutured. 
Each half of the suture in the left corner of the vessel Will 
Right, 
miiXI .. 
hepatic: 
Vllt", 
------- -
be run around half of the (I rcumierence at the vessel (Fig. other half of the left suture is then run over-and-over on the 
1.39Al. The posterior half will be tirst broU!olht inside the lumen anterior wall. completln~ the anastomosis IFig. 7.39Cl. The 
ot the vessel and then the contmuous suture wlil be pertormed ri~ht corner stay stitch is also tied snu~ly. For vessels oi 
trom within the lumen. As shown In Figure 7.39B. a middle medium or small caliber we use a ··growth iactor"·}; that is. 
suture also was placed. which will elevate two ··rldges·· of tis- the suture used for anastomoses IS tied some distance away 
sue to iacilitate the eversion oi the posterior anastomosIs. The irom the wall of the vessel (one half to one diameter I while 
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the stav suture is tied down snugly (Fig. 7.~OA.Bl. In this 
manner. the redundant runner can distribute Itself along 
the penmeter or the vessel. once It distends with blood aiter 
unclamplOg. The suture placed 10 the right corner oi the 
\'essei prevents the nght angle lrom openmg. This small arti-
iice prevents an hourglass stricture at the anastomosis. 
Although particularly mdicated for venous anastomoses. the 
~rowth iactor aiso IS frequently used in end-to-end artenal 
anastomoses. 
The suprahepatic vena cava IS sutured with 3 -0 Prolene 
I Figs. 7.!11-1 .~31. and the inrrahepatlc cava IS sutured with 
4-0 Prolene IFigs. 7.44. IA5\. Before the inrrahepatlc caval 
;lOastomosis IS completed. the liver is tlushed through the 
portal cannula with 100 to 500 cc oi cold lactate Ringers 
solution. depending on its size. This serves to l1ush out oi the 
liver anv previouslv entrapped air. as well as the preservation 
solutIOn. which has a high potassium content. The portal 
cannula IS then clamped and removed. The portal veins on 
both the donor and recipient Sides are then trimmed for 
anastomosIs. It is better to trim as little as pOSSible on the 
I Runner 
before 
tieing 
Figure 1.40 
Figure 7.42 
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B 
recipient Side. in case the patient has to undergo retrans-
plantation at a later time. In any case. the vems have to be 
just snug arter one or more laparotomy pads are placed 
behind the liver. The tendency IS to leave the veins too long. 
but later. when the viscera now retracted inieriorlv are 
released and returned to a normal pOSition. the resulting 
vein can be too long and kink. In fact. the veins must look 
almost too short to ensure that the ultimate length is cor-
rect. Once the two veins have been trimmed. they are anasto-
mosed in an end-to-end fashion With 6-0 Prolene. leavmg a 
one-diameter growth factor I Figs. 7.46. 1.4 7l. The clamps 
are removed and the liver is revascularized. It should reper-
fuse evenly and remain soit (Fig. 7.481. Rapid inspectIOn of 
the anastomoses is then perrormed and hemostasis of major 
bleeding pomts achieved. 
IMPLANTATION (ARTERIAL ANASTOMOSIS) 
If not already done. the reCipient hepatiC artery is now mobi-
lized to a level at least 2 to 3 em prOXimal to the gastro-
duodenal artery bifurcation. The anastomoSIS site on the 
Figure 7.41 
Figure 7.43 
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recipient side depends on the len~th and caliber of the donor 
vessel. Fillure 7.49A-D shows the various anastomoses of the 
hepatiC artery possible In the recipient: at the proper hepatic 
Jrterv level IA). at or near the Ilastroduodenal artery takeoii 
level -(8). at the common hepatic artery level IC). o~ encom-
passin~ the bifurcation of the ceilac a.'os Into the spleniC and 
common hepatic artery ID). 
\ Carred patch is always removed around the ceilac and/ 
l)r superior mesentenc artery irom the aortic wall to iacili-
Inferiar---+--
vena cava 
Gastroduodenal---t---+/ 
artery 
(recipienti 
tate the anastomosis to the recipient vessel. On the recipient 
side. the openm~s of two branches can be interconnected. 
resuitlnf.\ In a --branch patch" IFill. 7.501. The anastomoSIs IS 
done with 6-0 or 7-0 Prolene. with or without a ~rowth fac-
tor. which is usually omitted if patches ICarrel or branch' 
are used. The liver is then rearterialized_ 
HEMOSTASIS_ The remalninll hemostasis is done at this 
POint. In a simple case. little or no hemostasIs is necessarv 
Left 
gastric 
artery 
~+---Celiac 
aXIs 
'''--Splenic 
artery 
Splenic 0_ 
A 
Left 
gastric 
artery 
8 
~--~~·~~----t----------Common 
Common 
hepatiC 
artery 
(donor! 
Figure 7.49 
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hepotlc 
artery 
( reclpienti 
c 
now. In difficult cases. with portal vein thrombosis or exten-
sive adhesions. many hours of tedious work are necessary. 
Sutures. cautery. infrared sapphire coagulator. argon beam. 
and hemostatic agents are used singly or in combination to 
achieve hemostasis. 
BILIARY ANASTOMOSIS 
ICHOLEDOCHOCHOLEDOCHOSTOMY-DUCT-TO-DUCTI 
This is the type oi biliary reconstructIon that we favor. It is 
simple technically. rapid. physiologic. and allows access to 
Donor celiac 
axis with 
Carrel patch 
of aorta Left 
the bile duct for monitoring of the bile and cholangiographic 
exams. Absorbable material is used for the anastomosis. 
either of the braided (Vicryl' or Dexon', or monofilament 
(PDS· or Maxon') type. 
The donor and recipient bile ducts are lirst trimmed to the 
appropriate length; care is taken to ensure that the margins 
are viable. Fine silk stay sutures are placed on the two cut ends 
(Fig. 7.SlAI. A metal probe is then introduced into the recIpient 
duct for 2 to 3 cm and pushed through a small stab wound. 
Electrocoagulation should never be used for this purpose. 
GaSIro-~ReciPient duodenal hepatic 
artery artery 
~ ~ 
Figure 7.50 
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because tissue destroyed by heat may cause a biliary leak during 
the postoperative course. After the probe has been pushed 
through. a 2-0 silk tie is knotted to its end (Fig. 7.51B) and the 
probe is pulled through the duct wall and out the cut end. A 
French-eye needle is loaded on the silk tie and passed through 
the end of the long limb of an Bor 10 French T-tube (Fig. 7.51C). 
which can then be pulled throu~h the same stab wound (Fig. 
i.51DI.At least a V-cutshould be made in the short limb oPPOsIte 
the lon~ limb to facilitate its later removal (Fig. 7.52A1. Alterna-
tively, the short limb can be sectioned longitudinally to form 
a gutter (Fig. 7.52B1. The T-tube is then pulled inside the recip-
Ient duct and out through the SIde hole. until the short limb 
I ies insIde the duct. Its superior end protrudes out of the cut end 
of the recipient bile duct and will cross the anastomosIs into 
the donor duct. 
--I---Common or 
hepotic 
bil.dud (donorl 
~--Common 
bil. dUd 
( recipient I 
A 
r----Sulure previously 
lied to probe 
Figure 7.51 
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c 
The anastomosis can now be performed either with 
running or interrupted sutures. If the running method is 
selected. the same technique as in a venous anastomosis is 
used. Two sutures are placed at the comers of the suture line 
and then two halves of the left suture are run around both 
the posterior and anterior walls (Fig. 7.53AI. The two ends 
are then tied at the right corner (Fig. 7.53B\' If interrupted 
sutures are used. we start with one posterior suture (Fig. 
7.54Al. following which serial interrupted stitches are placed 
in successIOn. moving on both sides toward the anterior wall 
(Fig. 7.54B1. All the sutures can be put in. tagged, and tied at 
the end. or they can be tied and cut as the surgeon proceeds 
(Fig. 7.54CI. The superior end of the short T-tube lImb is 
introduced into the donor duct just before starting on the 
anterior wall of the anastomosis. 
, 
i , 
! 
/ 
Pulled through 
stab wound 
8 
o 
Figure 7.53 
Figure 7.52 
~--------Common 
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A B 
-\---------------------- Common bile 
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stitches 
B 
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When the anastomosis has been completed. it is checked for 
leaks. This is done bv tirst tloodin$.l the area with saline solution. 
then InJectIn$.l air throulolh the T-tube. and finally by pertorm-
In$.l aT-tube cholan$.llogram I Fi$.l. 7.55), For small leaks. Indiv-
idual fine absorbable sutures are sufficient: tor lar$.le leaks. a 
complete revIsion of the anastomosIs is necessarY. 
Figure 7.55 Figure 7.56 
Figure 7.58 Figure 7.59 
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The complications of the choledochocholedochostomy are 
the followin$.l: 
1. Dysfunction of the sphincter of Oddi. leadin$.l to a dif-
fuse dilation of both the recipient and donor ducts J6 
(Fig. 7.56). This is corrected by conversion to a chole-
dochojejunostomy with a Roux-en-Y loop. 
rw, 
Figure 7.57 
Figure 7.60 
2. Bile extravasation. either from the suture line (Fig. 
7.57) or the T-tube exit site (Fig. 7.581. It can be cor-
rected either by primary repair or conversion to a 
Roux-en-Y choledocho;e;unostomy. depending on the 
size of the leak and degree of contamination. 
3. Stricture. Single strictures usually occur at the anas-
tomosis (Fig. 7.59). Multiple intrahepatic strictures 
usually are the result of arterial thrombosis. Balloon 
dilatation can be attempted for single strictures (Fig. 
7.60l. although most patients will eventually require a 
conversion to choledochojejunostomy. 
The overall incidence oi complications aiter choledocho-
choledochostomy is approximately 18%. which is consistent 
with that found in the series from other centers. using this 
or different reconstruction methods. The advantage is that 
Figure 7.61 
these complications usually can be dealt with rather easily 
and definitively by a conversion to a choledochojejunostomy. 
BILIARY ANASTOMOSIS (CHOLEDOCHOJEJUNOSTOMy) 
This procedure is used in the great majority of pediatric patients. 
who have absent or small caliber ducts. and adult patients with 
either primary diseases involving the biliary tree (primary 
sclerosing cholangitis. Caroli's disease). cancer. or a major dis-
crepancy between the donor and recipient ducts. 
First the donor duct is trimmed to viable tissue and hemo-
stasis of the margins is achieved. Then a 40-cm-long Roux-
en-Y loop of jejunum is fashioned. Either hand-placed 
sutures or staples can be used. depending on the surgeon's 
preference. Figure 7.61 shows a Roux-en-Y loop performed 
with stapling devices. A small incision has been made in the 
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antimesenteric border of the Roux-en-Y. which will be anas- or 10 French Silastic· tubing with additional side holes and 
tomosed to the donor's bile duct placed across the anastomosis. The stent is kept in place by 
The biliary anastomosis is then performed using either a single 5-0 chromic suture tied loosely to allow it some 
running or interrupted sutures just as for the choledocho- movement during the performance of the anterior anasto-
choledochostomy (Fig. 7.62). A small stent is made out of 8 mosis. Testing of the anastomosis by air injection and chol-
__ IBlI ___________ ~~.·=_TiR'P'·rr PI ~::u:" ,_c· ~ 
Figure 1.62 
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Chrorllic catgut 
stitch 
Tip of jejunal 
Roux-en-Y limb 
(recipient, 
Figure 1.63 
Portal v. (recipientl 
angiogram can be done uSing a cholangiography catheter 
placed inside the cystic duct I Fig. 7.63) if the latter joins the 
hepatic duct above the level of the anastomosIs. 
The complications ot this reconstructive method are as 
follows: 
1. Bile leaks. which are usually anterior. Revision of the 
anastomosis is necessarv. although In the presence of 
extensive contamination temporary external drainage 
may be the only viable solution. 
2. Strictures. If they occur at the anastomosis. strictures 
can be readily managed With percutaneous balloon 
dilation. 
3. RetentIOn oj the stent can cause biliary obstruction. 
This is treated by percutaneously pushing the stent 
into the bowel or bv extracting it operatively. 
- ---- - --
4. Ascending cholangitis. although rare with a defunc-
tionalized limb. can occur. It will require antibiotic 
treatment. Repeated recurrences may require a revI-
sion of the Roux-en-Y loop. 
5. A "blind loop syndrome" may sometimes be diagnosed 
posttransplantation. Long-term oral administration oj 
tetracyclines is curative. 
CONCLUSION OF THE OPERATION 
At the end of the biliary anastomoSIS. the gallbladder is 
rapidly removed with the electrocautery. proceeding from 
the fundus toward the neck (Fig. 7.64), The cystic artery and 
duct are ligated with silk_ The hemostaSIS is checked one 
more time; then closed suction drains are placed around 
and behind the liver IFig. 7.65). The abdomen is closed in 
Suprahepatic inferior vena cava (recipient! 
Inrrahepotic" 
inferoor ", 
vena cava 
(donor! 
__ ::Z:~~~::::;::~~\:=~--Suprahepatic inferior vena cava (donor! 
Cloud oucl',on,--I-
drain A 
Figure 7.65 
Closed ... ,.t""r. __ -
drain II 
Aorta 
( recipient! 
Portal v. 
(donor! 
Hepatic 0, 
(donor) 
HepatIC o. 
(recipient! 
Portal v. 
( recipient! 
f;)j--\'"-------Closed suction 
drain C 
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Figure 7.66 
inferior vena cava 
Figure 7.68 
Posterior 
of the 
Figure 7.67 
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7.32 ATLAS OF ORGAN TRANSPLANTATION 
Bare 
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vena 
cava 
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inferior vena cava 
(diaphragm sidel 
Esophagus 
Posterior 
comman 
bile duct 
Posterior 
portal vein 
layers and the skin margins are approximated with staples. 
as demonstrated in Figure 7.66. 
Modifications of the Basic Procedure 
Various modifications of the basic technique have to be used 
under certain circumstances. These techniques will be de-
scribed in the same order: hepatectomy. venous anastomo-
ses. arterial anastomoses. and biliary anastomosIs. 
MODIFIED HEPATECTOMY 
The hepatectomv can be extremely difficult in the presence 
of adhesIOns from previous sur~ery. Sometimes the hilum 
simply cannot be approached antenorly. so the upper vena cava 
Relrohepatic 
inferior --\t~-::~~~ 
vena cava 
Bare 
Infrohepatic---zoiIi::==s-"-.,.....--",.~ 
inferior 
vena cavo 
D~um-----------4-
Figure 7.69 
must be defined first. clamped on the two sides and divided. 
with the liver then being mobilized posteriorly (Fig. 7.67\. 
Because this mobilization proceeds from cephalad to caudad. 
the hilum can be approached from the posterior aspect. which 
is relatively free of adhesions (Fig. 7.68\. 
Another situation is that of extremely tenacious adhesions 
present around the suprahepatic vena cava. In this instance. 
the infrahepatic vena cava can be divided between clamps 
and the dissection done posteriorly. proceeding from a cau-
dad to a cephalad direction !Fig. 7.69\. 
In the presence of scar tissue around the infrahepatic cava. 
or when a patent end-to-side portocaval or mesocaval shunt 
is present. the liver can be completely dissected off the retro-
hepatic vena cava. All the secondary hepatic veins are ligated 
Portal vein 
with cannula 
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and then a clamp is placed across the main suprahepatic 
veins-the openmg of which will be interconnected in order 
to fashion a common funnel (Fig. 7.iO). The vena cava is 
thus never mterrupted. The openings of the suprahepatic 
veins are then interconnected. so that the donor liver can be 
anastomosed to this common funnel in a piggyback fashion. 
The donor infrahepatic cava can be simply ligated. 
Figure 7.70 
Portal vein 
with cannula 
otcanlluence 
01 superior 
mMelltericv. 
and splenic v. 
Figure 7.7J 
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MODIFIED VENOUS ANASTOMOSIS 
When the portal vein is thrombosed. extremely friable. or 
considerably smaller in size than the donor's vessel. the dis-
section in the recipient must proceed until the confluence of 
the splenic and superior mesenteric veins is visible, with 
enough room to spare for placement of a vascular clamp (the 
so-called "classic approach"). Depending on the specific situ· 
ation. the superior mesenteric vem mayor may not be can-
nulated for bypass (Fig. 7.71\' Even m cases of thrombosis of 
the main trunk. the portal vein is usually patent at this level. 
The venous anastomoSIS can then be done directly if the 
donor vein is long enough; if not. a free interposition graft 
(from iliac vein harvested from the donor) is necessary to 
bridge the gapJ9 (Fig. 7.721. The recipient portal vein-graft 
anastomosis is done during the preliminary dissection 
phase: the vessel is then flushed with heparInized solution 
and clamped distally. The grait-donor portal vem can then 
be periormed at the appropriate time. before unclamping. 
OccasIOnally, the only patent vessel is the superIor mesen-
tenc vein, in which case a free graft will have to be either 
tunneled under the pancreas (after infrahepatIc anastomosIs) 
or anteriorly over the duodenum. Although they may seem 
rather straightforward. these situations are exceptionally 
complex and difficult because of the extensive dissection 
required in the presence of unusually high portal hyperten-
sion and large collaterals. In some instances. we have been 
forced to divide the pancreas transversely to have sufficient 
exposure and control of the superior mesenteric vein. 
More recently. a much easier way of bypassing the throm-
bosed portal vein has been devised.4° The superior mesen-
tenc vein is identified under the transverse mesocolon (just 
to the right of the superior mesentenc artery, which can be 
palpated with ease) and freed from the last branch contlu-
ence to the inferior border of the pancreatic neck. A tunnel 
can then be made bluntly in the avascular plane found 
between the anterior surface of the pancreas and the poste-
rior wall of the pylorus. A free iliac vem grait is then anasto-
mosed in an end-to-side fashion to the superior mesenteric 
vein. The grait is threaded through the tunnel and anasto-
~. rOlna. vein (donor! 
Inferior 
mesenteric 
vein 
---------------------Su~r 
Figure 7.72 
mesenteric 
vein 
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mosed end-to-end to the donor portal vein (Fig. 7.73l. This 
method IS very simple and rapid. and presents a low degree 
of technical risk. In fact. this approach has virtually elimi-
nated portal vein thrombosis as a contraindication to trans-
plantation. be it absolute or relative. Naturally, with either 
method the portal component of the venovenous bypass IS 
omItted. and only a femoroaxillarv bypass is used. 
MODIFIED ARTERIAL ANASTOMOSIS 
The previously descnbed technique applies in the straight-
forward cases. However. there is enormous potential variabil-
Ity With regard to the hepatic artery, and the surgeon should 
be aware of the need to modify the standard approach. 
In general. is it preferable to use Carrel or branch patches 
for arterial anastomoses: these will allow Wide openmgs, 
without the danger of stenosIs and thrombosis. On the donor 
Side. the aortic Carrel patch. the ceilac axiS. or the splenic/ 
(ommon hepatiC bifurcation are the most trequently selected 
Porto" 
vein ~ 
(donor! 
Jump graft 
Portal vein 
! recipientl 
Duodenum---+-
vein 
Figure 7.73 
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sites_ When a bifurcation is used. the two branches are sev-
ered a few mill imeters downstream and the openings are 
then interconnected by cutting the septum in between. The 
branch patch thus obtained can be trimmed to the appropri-
ate size and shape. On the recipient side. the same technique 
is used for the bifurcation ot the proper hepatIc artery into 
the right and left hepatic branches. the bifurcation of the 
common hepatic and gastroduodenal arteries. or the bifurca-
tion of the celiac axis and splenic artery. In the latter case. 
the splenic artery can be completely divided between ties or 
the sectIOn can pass tangentiallv over the cellae and splentc 
openmgs, the resulting oblique openmg havmg a large diam-
eter. In general. a right branch ongmatmg trom the supenor 
mesentenc artery is not used for reartenalization of the liver 
unless it is the dominant vessel. 
When for whatever reason the intlow is unsatisfactory, an 
interposition graft can be used. 41 This can be a small straight 
segment placed between the reCIpient celiac axiS just distal 
Figure 7.74 
to the takeoff of the left gastric artery and the common hep- graft is tunneled under the pancreas and the root of the 
atic artery of the donor. in cases when the two vessels cannot mesentery to reach the hepatic hilum. The formation oi the 
be approximated directly without undue tension (Fig. 7.74), tunnel can be seen from an anterior view (rig. 7.75A) and 
or it may be a long segment placed between the recipient's from a left sagittal view (Fig. 7.758). Several routes have 
infrarenal aorta and the donor's vessel. In this latter case. the been employed, either to the right or left of the superior 
B 
Fig.". 7.75 
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mesenteric artery. Fi~ure '.76 shows the long route IAl. the 
short route IBl. and the very long route IC). The short route. 
gOing In a straight line to the hilum. is riskier because It may 
Injure the more numerous collaterals behind the head ot the 
pancreas. The route involvmg the least risk probablv is to the 
right at the superIor mesenterIC artery. passmg on top at the 
vena cava. However. this route mav prove to be too long tor 
the available gratt. and positIOning the donor artery without 
kinking can become more difficult because the a;terv IS to 
: he right oi the portal vem. The preferred route is to make a 
tunnei antenor to the pancreas and behind the stomach. 
rasslng through an avascular and consequentl\' danger-free 
.Irea" I Fig. 7.771. 
.\nother technique is the direct anastomosIs Of the donor 
jortlc Carrel patch to the reCipient supracellac aorta I Fig. 
7.731. The aorta IS dissected durmg the anhepatlc phase and 
then a :iatmsky clamp IS used tor the anastomosIs. The expo-
Hepatic a .. 
Idonor) \ 
Portal, \ 
vein \ 
Idonor) \ 
\ \ 
\ 
·,..j.-I----Graft 
sure for this type or anastomosIs is suboptimal. but it mav be 
the only viable alternative in the case oi a calcified infrar~nal 
aorta. Longer graits have been used occaslOnaliv. but With-
out long-term success. . 
The gratts used are Iliac artenes harvested from the donor. 
If the speCific donor could not prOVide adequate grafts 
\ either because at the presence 01 lower poiar renal arterIes 
With iliac takeoii or because 01 catheter thrombOSIS). artenal 
graits or the same blood tvpe but from a different donor can 
be employed. Svnthetlc grafts are aVOided. given the verv 
high rISk of infectIon in immunosuppresseo patients. 
MODIFIED BILIARY ANASTOMOSIS 
The so-called Waddel-Calne gallbladder conduitO also can be 
used. The gallbladder is mobilized. but the cystic artery and 
duct are leit untouched. The neCK oi the gallbladder is anas-
tomosed to the donor common bile duct. then the fundus or 
Gastroduodenal' 
artery 
Left'" 
gastric 
artery 
Donor 
hepallc 
artery 
-4---Aorta Figure 1.78 
Superior' 
",esenteroc 
vein 
Figure 7.77 
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the gallbladder can be anastomosed to the donor's common 
bile duct or intestine tFig. 7.791. This reconstruction permits 
a larger stoma between the donor and the recipient. but it 
involves two anastomoses and a large saccular structure in 
the middle of the biliary tract reconstruction. Although the 
favorite of the Cambridge group, this method has been rarely 
used by us. 
LIVER TRANSPLANTATION IN 
THE SMALL PEDIATRIC PATIENT 
Liver transplantation in the relatively lar~e pediatric patient 
135 Ibs or more) is essentially the same from the technical 
point of view. Naturally. in dealing with smaller and more 
delicate structures. maximal care must be exercised during 
the operation. Bypass can be used. usually with a pediatric-
size pump. Blood loss must be kept to a minimum. ~iven the 
small total blood volume of the child. A choledochojejunos-
tomy IS almost always used in the biliary reconstruction. 
because a good percenta~e of pediatric patients are trans-
planted for biliary atresia and because the size of the bile 
duct is too small for a safe duct-to-duct anastomosis. 
On the other hand. the very small pediatric patient pre-
sents some special problems:"'·45 Venovenous bypass cannot 
be used. because the extremely low tlow would predispose 
to almost certain formation of emboli. Fortunately, such 
patients tend to tolerate cross clamping of the venous flow 
quite well. There are frequently extensive adhesions from 
multiple previous portoenterostomies as well as external 
stomas. The baby is often malnourished and infected from 
cholangitis. The arterial anastomosis is a major challenge 
because of its small diameter. Creative use of grafts teither 
il iac. as previously described. or carotid and aortic conduits 
-Fig. 7.801 must be employed. Because a liver of appropri-
ate size cannot always be found. a lar~er liver must some-
times be trimmed down by means of a partial hepatectomy 
to be able to fit the or~an in the small abdominal cavity.46 
tFigure 1.81 shows a left lateral se~ment being used for 
implantation.) The use of coagulation products during the 
operation is avoided. because it would predispose to arterial 
thrombosis. Thus. the hepatectomy must be done almost 
bloodlessly to avoid subsequent diffuse bleeding after reper-
Com~bllll----------------t­
duct (recipientl 
Figure 7.79 
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fusion. Postoperatively. the patients receive low molecular 
I\'eillht dextran and low dos~s 01 heparin or aspirin in an 
effort to avoid thrombosis. This has been partlcularlv effec-
tive in our experience.-' 
POSTOPERATIVE MANAGEMENT 
Early Period 
\tter surgery. the patient is transferred to the intensive care 
Unit. where he or she will speno the next 24 to ,2 hours Ilor 
:.mcomplicated cases!. Depending on the preoperative condi-
tion. the magnitude and duration Of the procedure_ blood 
,IISS. and other factors. the patient will neeo mechanical res-
I'lratorv suppurt lor a vanable length ot time. but rarelv less 
than 18 to 24 hours.:\s might be expected. the mOnItonng of 
these patients IS Intense and complex IFig. i.S~I. 
Sedatives and narcotics are a\'olded as much as possible so 
as not to cloud the sensonum. Interestingly. the oyerwhelm-
Inll malOnty ot orthotopIc liver transplantation patients do 
nut expenence Significant pustoperatlve pam. 
Because of intraoperative fluid overloading and cvclospor-
Ine administration. most patients tend to become hyperten-
sive. :\gllresslve and earlv treatment IS mandatorv. because 
the still-abnormal coagulation predIsposes to Intracerebral 
hleedinll. whIch IS Irequentlv lethal. The diureSIS must be 
maintained at adequate levels. iJiuretlcs and intravenous col-
:')Ids Icrystallulds are usually lost In the .. third space' in liver 
~atlentsl must be used generously. alone ur In combination. 
The pulmunary tOilet is extremeh' Important. especlallv 
.lIter long. dlliicult transplants. Chest phvslotherapv and 
endotracheal suctlOnIng must be emploved aggressIve Iv. 
Ilroad spectrum antibiotICS !Usuallv thIrd generation 
(ephalosponnesl are administered for :2 to 5 days. Stress' 
ulcers are prevented bv administration of antaCids as otten as 
POSTOPERATIVE MONITORING 
Tests and Parameters 
necessarY to keep the gastnc pH hillher than 5. Sucraliate IS 
also Illven routrnelv. In addition. nYstatin (Mvcostatrn I IS 
adminrstered orallv land In lemales also vaginaily) to prevent 
secondary fungal infections. 
The baSIC immunosuppressIon is listed in Fi~ure 7.83. 
If rejection occurs. one or two additional boluses 01 meth-
ylprednrsolone 11 ~ IV) are administered. If a partIal response 
is obtained. a "recycle" Irepelitlon Of the prlmarv sterOid 
tapenn~ scale I is Iliven. Repeated episodes 01 acute relectlon 
or sterOid-reSistant releclIon are treated \\,Ith the monoclo-
nal antl-T-cell anlibodv preparation Illf\T3) Ilirthocione I. 
~\ild recurrent relectlOn or hl~her than antiCipated (\'clo-
'[lOTine tOXICltv can be treated With the audition or azathlo-
pTine ilmuran ).1).5 to 1.5 mg/kg/da\' In a Single dose. With 
or WIthout concomitant reductIOn of the cvclosporlne uose. 
If necessary, uKT3 can be repeated II no antlmUTIne antl-
hodies can be detected In the patient's serum. 
FK 506 
FK 506 is a new ImmunosuppreSSive agent that has been 
extensive Iv studied at the UniverSlt\' Of f'ittsbur~h since 
1987. It has demonstrated enormous potential in experi-
mental and clinical liver. heart. and kidney transplanta-
tion.""'! The mechanrsms 01 action 01 this a~ent are not \Tt 
entlrelv known. but appear to Im'olve Interleukin 2. 
While not entirely Without Side effects.' -." FK S06 seems to 
have less toxicity than cyclosporlne: ,,' 'I also IS about 11)1) 
~Imes more potent. At the present time. J rJndOmlZeLl cllnl-
(Ji trial is being conducted at the l:nlversltv 01 Pittsburgh to 
compare FK S06 With cyclospoTine. Jnd two multicenter 
trials are alreadv underwav In thiS countrv and In Europe. 
I'rom the data accumulated so lar. It JPpears that FK :i06 will 
replace cvclosporrne as the cornerstone 01 Immunosup-
pressive therapy. 
Frequency 
ECG. systemIC arterial tracing, central venous 
tracing. pulmonary artery and/or wedge 
tracing, pulse oximeter 
Continuous 
Urinary output 
Mental status 
Complete blood count. serum electrolvtes, 
coagulation, blood sugar, Mg", Ca';. H,PO.-, 
blood urea nitrogen. Cr 
Liver function tests (bilirubin-totalldirect-
SGOT. SGPT. alkaline phosphatase. gamma-
glutamyl transpeptidase), cyclosporme level. 
chest x-rav 
Figure 7.82 
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Every 2 hours 
Frequently 
Every 6 hours for the first 24 hours. 
then every afternoon: more 
frequently if necessary 
Every mormng; more oiten if 
necessary 
Late In-Hospital Period 
When stable. the patient IS moveu to the regular ward. Rapid 
.lmbulation follows: oral Intake IS started and rapidly ad-
\'anced. No Isolation precautions are undertaken unless spe-
cific circumstances dictate It. In fact. as soon as the patients 
Jre sufiicientlv active. they are even ailowed to leave the hos-
pital for a few hours a uav. The comolete blood count. serum 
electrolytes. renal lunctlon. bloou sul1;ar. coa~ulatlon. liver 
iunction tests. and cyclosponne level are measured daily. 
Total serum protein. albumin. La". )1g'-, H,PO,-, amylase. 
.lnu UTiC aCid are measured tWice w~eKlv. The Immunosup-
;'resslon IS rel\ulated aCCOrding to the ciinl"ll picture and 
~\'C10SpOTlne bloou levels. If a T-tube has heen placed. a T-
~ube cholanlllOllram IS perrormeu as soon as the bilirubin is 
~ m!Vdl or less lusuailv alter 1 to to davsl and. if the study 
results are normal. the tube IS clampeu IFi!!. 1.341. This 
,dlows Improvell absorptIOn 01 the oral cvclosporlOe: the 
Intravenous drUI\ usuallv can De discontinued at thiS tIme. 
When the patients condition IS stable anll the Immunosup-
rresslve regimen regulated 13 to 4 weeKs iO the uncompli-
cated casel. the patient can be discharged and be followed iO 
the outpatient deoartment. 
BASIC IMMUNOSUPPRESSION 
Agent Dose and Frequency 
Low-dose trimethoprimlsulfamethoxazole and high-dose 
acvclovir are given for at least 1 vear as prophylaxIs lor 
Pneumocystls carinii, herpeSVirus, anu cytomeJ;jalovlrus 
infections. 
Outpatient Period 
InItialiv. the patient IS seen In the ou[patlent department 
tWice a week. In addition to clInical evaluation. serum elec-
trolytes. blood sUl1;ar. blood urea nItrollen. creatinIne, pro-
thrombin and parlial thromboplastin times. complete blood 
cuunt. liver function tests. anu unc aCiu are measured. The 
cyclosporine level IS checked as weil. The Immunosuppres-
sIOn is line-tuned dUTlng thIS peTiod and. frequent lv, the 
sterOids can already be lowered to 15 mg/day. If stable after 
the first 2 to 3 weeks. the patient IS seen In the outpatIent 
department once a week for another I to :) weeks and then 
Jischarl1;ed home. In the care 01 the ramIiy phYSICian. The 
-:oordmator assll1;ned to the case wIi I keep In contact With the 
patient. Laboratory exams are continued weekly for 1 to 2 
months. then at increasm~ly longer Intervals. Eventuallv. 
the patient needs to be checked bv the local phYSIcian OnlY 
Cyclosponne Ii m~1 kll/day IV in two divided doses: as soon as the 
gastroIntestInal transit is established. 20 mg/kg/day or' 
oral cyclOsponne IS added In two divided doses. Arter 
<lverlapplng lor a lew days. the IV cyciosporIne IS 
graduailv tapered. while the absorption or' the oral drug 
Improyes. The cYciosporine level will help gUide and 
Individualize the therapy 
Steroids 
Figure 7.83 
I g of IV methylprednisolone IS ~iven Intraoperativelv, 
immediately alter reperluslon: a tapering regimen IS 
then arimlnlstereO: 
50 m~ IV Q.tih x 4. then 
40 mg IV Q.tih x 4. then 
30 mg IV Q.tih x 4. then 
20 m~ IV Q.tih x 4, then 
20 mil IV q.l2h x 2. then 
20 m~ IV Q.d. Prednisone IS substituted lor 
methvlprednIsolone once intestInal transit is 
reestablished 
Figure 7.84 
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1:\\10 to four times a year. The only other reqUIred visit to our 
llutpatient department is at 1 year after transplantation. 
when an abdominal ultrasono~raphic exam IS penormed 
;llon~ with the routine laboratory tests and a thorou~h 
clinical checkup. 
COMPLICATIONS 
Primary Nonfunction 
of the Homograft Liver 
This complication occurs in 0.9 to 10% of our cases.bubl and 
I t is expeTienceo immediatelv after transplantatIOn. Primary 
nontunctlOn can result trom an unstable donor. preexlstln~ 
disease In the donor. Inadequate or overiy lon~ preservation. 
an Imperrect recIpient operation. or a penoperatlve Immu-
nolo~lc reaction. These lactors can occur separately or In 
combinatIOn. 
In a ma,lontv of the cases oi pnmarv liver noniunction. the 
liver produces little or no bile aiter repenusion: the preexlst-
In~ coagulopathv worsens (or occurs de novol. and the lac-
tate level fails to decrease or even tncreases. Occasional Iv. the 
liver functIOn is good or fair dunng the first 24 hours or so. 
only to deteriorate rapidly alter. PostoperatIvely. the patient 
IS either comatose or extreme Iv agitated. and the bile output 
IS minimal (if a T-tube IS present!. With mucous. greemsh 
hile. The UTine output usually decreases. With a concomItant 
Increase tn the blood urea mtrogen and creattnlne. The coag-
ulation parameters are abnormal: the liver enzymes are very 
high. and the bilirubin increases rapidly. If the situation does 
not Improve within 24 to 36 hours. the patient's on Iv chance 
for survival lies With emergency retransplantatIon. Recentlv, 
repeated sessIOns 01 plasmapheresIs have been used bv us 
With notable success tn buytng time to allow the liver runc-
tion to return to normal (unpublished matenall. 
The morbidity and mortality of this complication are 
high.b2 Survival followtnl! retransplantatlon for pTimary non-
functIOn IS onlv half of that seen rn the general liver trans-
plant population. Overall. it is the most lethal of all pOSSible 
complications 01 liver transplantatIOn. Attentive selectIOn 
of the donor. careful management. perlect harvesttng tech-
nIque. optImal preservatIOn. and uncomplicated recIpient 
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operation are each an essential factor in the struggle to min-
:mlze the incidence or primary noniunction. 
Re;ection 
The eXIstence 01 hvperacute rejectIon In liver transplantatIon 
leven when the transplant IS done across blood group linesl 
IS a controversial subject. and the eVidence supporting or 
reiutin~ it is incomplete at besLbJ-o' There IS no good. reli-
Jble eVidence ior it. and the diagnosis is usually one oi ex-
clUSion when there IS no reason to believe that the ~ratt is 
or poor quality-especlallv when two or three livers trans-
pianted in rapid succession do not lunctlon. We call these 
patients intormallv "liver eaters" and believe that a humoral 
Immunologic lor possibly nommmunologlc) mechanism can 
explain the livers repeated failure to lunctlon. 
On the other hand. acute cellular reJection occurs In at 
least YO% of the patients at one pornt or another during the 
postoperative course. usually 7 to 10 days arter orthotopic 
i Iver transplantation. There IS a mild to moderate elevation 
IJf the liver function test results (frequentlv the bilirubin and 
the "secretorv' enzvmes-alkaline phosphatase and gamma-
~Iutamyl transpeptidase-are affected In a greater meas-
urel. If a T-tube IS present. It wIiI be noted that the bile IS 
li~hter In color and consistency, AlthoulI:h the dia~nosls can 
he made on clinical grounds alone. a liver biopsy Will give a 
definitive answer."· The differential diall:nosls includes 
Ischemic in,iury. hepatitis (A. B, or non-A/non-S. cytome~­
alovlrus. herpes simplex. adenovlrusJ. sepsIs. biliarv tract 
complications.;" The treatment gUidelines [or liver rejection 
Jre listed In Fi!-lure 7.85. 
Sepsis 
SepsIs IS common in transplant patients In general because 
"t immunosuppression. It mav be related to technical com-
plications (biliary leak. artenal thrombOSIS. intestInalleaksi. 
catheters Icentral venous. unnarVJ, or ovenmmunosuppres-
sion tbactenal. Viral-espeCially cytomegalovirus and herpes 
Simplex virus-fungal. protozoal/. The diagnosis is based 
on appropnate cultures. and treatment IS directed against 
the infectious agent(s) based on specIfic sensitivities. Early 
and aggressive diagnosIs and treatment are mandatory. as 
the immune system is depressed. A host of noninvasive and 
invasive procedures can be used for diagnosis. including ultra-
sonography. computerIZed tomography. abdominal paracente-
sis. thoracentesis. gastrointestinal endoscopy. bronchoscopy 
with bronchoalveolar lavage. lumbar puncture. percutaneous 
drainage oi collections. and exploratory laparotomy. 
LIVER REJECTION TREATMENT 
Type of Rejection Therapy 
Technical Complications 
ARTERIAL THROMBOSIS 
Arterial thrombosis is a very serious complication in liver 
transplantation. This is easy to understand. considering that 
the new liver has no collateral circulation and that the hep-
atic arterial flow is the only blood supply to the donor biliary 
tree. Early thrombosis is almost invariably a disastrous event 
(see Fig. 7.86 for clinical deSCriptions and treatments).ll 
Mild. mild-to-moderate Steroid bolus (1 II methylprednisolone) 
Moderate Steroid bolus and recycle (tapering scale repetition) 
Severe OKTl (includa 1 g hydrocortisone on the first day 
and 0.5 II hydrocortisone on the second day. prior 
to infusion) 
Recurrent mild Repetition of the steroid bolus with or without a 
recycle 
Recurrent mild. severe. OKTl 
or steroid-resistant 
Persistent mild Azathioprine. 0.5-1.5 mg/kg/day 
Figure 7.85 
ARTERIAL THROMBOSIS 
-.... - . .,.----.--..- .... -;--.-~- . 
ClInical Description . '7.. '. -.;;: .:: T ........ t 
Massive necrosis (rare. but extrCmely -: , .. Urgent retransplantation 
lethal') ,.' .. <o.:~...>i.'.. _" ~ 
Biliary leak (due to necrosis and 
sloughing of anastomosis) 
Central hepatic biloma (due to central 
necrosis of the biliary tree, without 
bile extravasation) 
~ ,0\-' 
Drainage and semiurgent 
retranspiantation 
Percutaneous drainage and delayed 
retransplantation 
... "It\or··.·C·_ 
Recurrent bacteremia. without Long-term antibiotic treatment; 
necrosis . ·~'_!<:·'_;~"t~. late retransplantation? 
'SeIPIC, 7.87. 
Figure 7.86 
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Figure 7.87 shows gangrene of the liver caused by Clostrid-
ium species after thrombosis of the hepatic artery. Late 
thrombosis caused by either anastomotic stricture or Intimal 
hyperplasia may be more forgivmg. due to the development 
of collateral circulation via adhesions. Figure i.88 shows 
a pediatric patient with hepatic arterv thrombosis and re-
arterialization of the liver by collaterals from the superior 
mesenteric artery. 
~-- ' 1!JI;. ." ... :: ~ ~t.: 
l' .-,{,~. I 
.1.'. • 
The diagnosis must be entertained each time there is a 
sudden deterioration of liver functIOn or a significant and 
otherwise unexplained elevation of liver function test results. 
Sonography with Doppler tracing usually is diagnostic: if the 
arterial pulse is present. thrombosis can be ruled out. On the 
other hand. if the pulse is absent. angiographic confirma-
tion IS mandatory before undertaking retransplantation.;2 
Because none of the frames oi the liver ultrasonogram with 
Figure 7.B7 Figure 7.BB 
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Donpler study shown in Fi~ure 7.89 reveals the characterIS-
tiC artenal tracIn~. the studv is consistent with thrombosis oi 
the hepatic arterv. A contirmatorv an~IO~ram I Fi~. 7.90) 
demonstrates the absence oi the hepatic artery. \Vhile await-
In~ retranspiantatlOn. antibiotics I intravenous or orall must 
he admmistered. 
BILIARY LEAK 
Bile extravasation can be seen Independentlv. apart trom Its 
Jssociation with artenal thrombosIs. in duct-to-duct anasto-
:noses. the extravasatIOn can occur at the anastomOSIS or. 
:nore orten. at the T-tube eXit site IFigs. 757. 7.58).::1 It is 
heralded bv rever. elevation ot liver tunctIon test results. and 
'1ile-stamed drainajle. The diajlnosls IS ~astly made with a 
T-tube cholanjllOgram. With the exception or verv small. 
Jsvmptomattc. incidental leaks rrom the eXit site. which can 
he manajlcd nonsurjllcallv. all other leaks necessitate urjlent 
expioratory laparotomy. Dependmjl on the tvpe and site oi 
extravasation. as well as the degree or contammatIon. the 
problem can be corrected with slmpie suturIng or the deiect. 
revision or the choledochocholedochostomv. conversion to a 
Houx-en- Y choledochoJejunostomy. or temporarv external 
JraIna>\e. 
I n cases or choledocholcjunostomv. the leak onginates 
from the anastomosIs and almost Invanably occurs on the 
Jnterior wail. The symptoms are the same as prevIOus Iv 
Jescnbed. The dia~nosls IS made with percutaneous trans-
hepatic cholan>\IOgraphy." :\lthough the leak rareiv can be 
controlled bv placIn>\ a tew Simple sutures. repair usually 
reqUires complete reVISIOn at the anastomosIs or temporary 
external drainajle_ 
HOLLOW VISCUS PERFORATION 
I )ccasIOnailv. leaks irom thelejunojeJunostomv are encoun-
tered in lIver transplant patients. Also. on occasion. per-
:orated peptic ulcers have been llescnbed. Treatment is 
Figure 7.90 
---
directed toward correction oi the leak and possible underlv-
i n~ cause. [n this respect. manajlement does not differ rrom 
that used In normal generai surjlery patients. The onlv 
difference consists in the need tor aggressive use or broad'-
spectrum antibiotics I includinjl ampMtericin B. because 
candidiasis always occurs with intestinal leaks) and possible 
temporary reduction or the immunosuppression. 
BLEEDING 
Bleeding can occur earlv. secondary to Inadequate hemosta-
sis.:' Reoperatlon IS usuallv reqUired. Peptic or stress ulcers 
also can be the source or massive bleedin~. as can be bleed-
in~ trom theiejuno_rejunostomv. Glcer qisease IS controlled 
with nonsurjllcal measures. unless the situatIOn is desperate. 
B[eeding rrom the jejunoiejunostomv can be watched. but If 
more than 5 U of blood are needed withIn 48 to 72 hours. 
reoperatlon IS indicated. 
Other sources for bleedIn~ are cvtome~a[ovirus involve-
ment of the ~astromtestmal tract and ruptured false an-
c u rvsms of the vaTlOUS vascular anastomoses. When an 
aorto~raft anastomosIs IS Involved. the patIent usuallv dies 
of exsangumation before operative Intervention can be 
undertaken. 
Nontechnical Complications 
CYCLOSPORINE TOXICITY 
NEPHROTOXICITY, The nephrotoxlcltv of cyclosporme 
was established soon alter the mtrolluction or the dru~ in 
humans.'· Althou~h generally dose-dependent lor rather 
blood level-dependentl. this tOXICltv may manifest itself at 
lower than predicted dosa~es In certaIn mdlviduals. Acute 
toxicity is reverSible arter cvCIOSpOTlne llosajle reductIon. but 
chromc toxlcitv causes permanent dama~e. interstitial fibro-
SIS IS the most promment ot the SIde er!ects.:'-'9 In general. 
the smallest eriective dose should be ~Iven. to aVOid renal 
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toxiCltv. In some patients. azathiopTine must be added to the 
immunosuppressIve regimen to allow saie reductIon or the 
cyciosponne dosage. 
Severe. acute nephrotoxicitv can be seen In susceptIble 
patients as a result oi hepatorenal syndrome. shock. sepSIS. 
pnmarv noniunctlOn. and concomItant administratIon 01 
uther nephrotoxic drugs. The Intravenous lorm 01 c)lclo-
sponne IS the most damagIng. l)osage reduction. or even 
temporarv suspensIOn is necessary to counteract the toxicity. 
High dosages or azathIOprIne or OKT3 can be glyen m the 
inteTim to prevent relectlOn. HemodialysIs also mav be nec-
~ssary until renal tunctlon returns to acceptable levels. 
HEPATOTOXICITY. The liver toxlcitv 01 cvclosponne 
,liso was described early in the course or human tnals.'" 
OccurrIng much less Irequentlv than nephrotoxlcitv. the 
hepatotoxIcity can be qUIte severe. although It IS usually 
relatIvely mild. It IS dIagnosed alter ruling out other causes 
of liver enzvme elevatIOn. as well as by monttonnl1, lor drug 
tOXICltv sIgns on the bIOpsy. A slight dosage reduction usu-
allY is sUlllcient to reverse the chanl1,es. 
NEUROTOXICITY. This can aliect either the central" 
nr the penpheral nervous svstem.'- and frequently both. 
Hestlessness. slurred speech. seizures. paresthesias tespe-
ciallv penoral and lower extremIty), chanl1,e in taste. and dys-
phagIa haye ail been descnbed alone or In combinatIon. The 
central nervous sYstem tOXICity at tImes can be so disabling 
r partlcuiarly In the eiderivi as to requIre comrlete though 
temporarY cessatIon 01 the drul1,. It can be restarted. In small 
ural doses. alter resolutIon ot the neurologic symptoms. 
()ne 01 the most trequent aspects oi neurotoxIcity. observed 
hoth early and late dUTIng the postoperative course. IS repre-
sented by tremors. These are rather tine. but extremely 
disabling at times. not allowlnl1, the patIent to perlorm Ime 
nr moderately line tasks such as wnting or USIng a spoon 
tor leedIng. Tremors Irequently are the lirst subiectiYe sIgn 
(,I CYClOsponne toxIcIty. A reduction In the drug dosal1,e IS 
normallv surllclent to resolve the symptom. 
HYPERTENSION. This aliects more than 50% 01 the trans-
rlant patIents who had never experienced It betore:'J ,. The 
mecnamsm 01 hvpertenslon In these patients remaInS lar\.1ely 
unclear. It IS dose-dependent to a large extent: a cyclosponne 
dusa\.1e reduction trequentlv is verv helpiul. The degree or 
hypertensIon can be verY signulcant. and aggressIve therapy 
IS needed to control it. The anglOtensIn-convertmg enzyme 
Inhibiting drugs captopnl or enalaprii. cumbined WIth a 
JluretlC. are the most etfective. althoul1,h many other al1,ents 
Jre useu. 
HYPERKALEMIA. .\5 WIth hyrertenslOn. the mechamsm 
15 unclear:" Verv severe hvperkalemla may occur In some 
rat1ents. PotassIum levels of 0.5 to i mEq/liter are not 
uncommon . ..\ stnct low-potassIUm diet IS mandatorY. along 
With hll!h dosages 01 sodium-potasslum-exchangmg reSIn 
rreparatlOns. Hemodialvsls must be used occaslOnaliv lor 
7.48 All AS OF ORGAN TRANSPLANTATION 
rapId reduction of the potassium . ..\ cyclosponne dosage 
reduction also IS ultimatelv necessarv lor control oi the 
hyperkalemia. . . 
HIRSUTISM. This can be partlcularlv bothersome In 
female patients. I t is lan~ely dose-dependent .. and usually 
less 01 a problem as tIme passes and the cyclosporme dos-
age IS reduced. When severe. it requires an earlv dosage 
reductIOn. Otherwise. a depilatorv cream IS used until the 
condItion becomes less acute. 
GINGIVAL HYPERPLASIA. :)imJiar to that observed In 
ratlents taking phenytOIn> it is generally dose-dependent 
and can be controlled by reducmg the c\'closponne dosage. 
OccaSIOnally. susceptible patients wIil exhIbit a hIgh degree 
or gInglyal hvperplasla on minimal dosages. Careful dental 
hvglene IS mandatorv In all patIents taking cyciosponne. to 
rrevent some 01 the problems related to this complIcation. 
RENAL FAILURE 
,\s mentIoned earlier. this complIcatIOn mav be the result 
01 cyciosporine toxicity. On the other hand. it is Irequently 
seen as a result of shock or. In general. large blood losses 
during orthotopIC liver transplantatIOn. as a worsening 01 
rreexlstmg hepatorenal syndrome. ur as a result 01 the use of 
nephrotOXIC drugs. partIcularly antibIOtics. It IS also seen In 
rnmary nonlunction. where It resembles the hepatorenal 
syndrome 01 fulmInant hepatiC failure." DialYSIS must be 
employed to control these patIents .. .\Ithough usuallv a tem-
rorary phenomenon. renal failure can be permanent at 
limes. reqUIring kidnev transplantatIon at a later date. 
DIABETES MELLITUS 
This occurs as a worsening 01 a preeXIsting condition or a 
do! novo result 01 sterOId admInistratlOn."-"' Diabetes melli-
tus IS noted early in a great number or patients during the 
period of high-dose sterOId administratIOn. and It usually 
corrects Itsell when the dosages are decreased. Occaslonallv. 
a patient who had not been diabetIC belore orthotopIC ItYer 
transplantation WIll require permanent treatment alter the 
operatIon. Also. patIents who preViously had been treated 
WIth only oral hypoglycemiC agents WIll require insultn aiter 
transplantatIOn. A reduction m the sterOId dosage IS usually 
helplul. at least in part. in controlling the hvperglycemla. 
OccaSIOnally. we have also stopped the sterOId therapy alto-
gether. treatmg the patlent WIth cyclosponne only. 
CUSHING'S SYNDROME 
:\ large percentage 01 patients \\Iii I acqUire some 01 the 
ieatures or sterOid-Induced CushIngs syndrome. These 
symptoms tend to improve WIth time. as the steroid dosalles 
are lowered. but occaSIOnally thev can be seen even WIth 
extreme Iv small amounts 01 the drug. 
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 
These lymphoma-like disorders are seen rn 1.5 to 2% of liver 
transplant patients. They are related to the Epstem-Barr 
virus. and occur as either new Iniections or reactivations of 
previous iniectlOn."' Posttransplant Ivmphoproliieratlve dis-
orders present with fever and Ivmphadenopathv. deteriorat-
ing liver iunctlon. Intestinal symptoms. or anv combination 
thereoi. A relatively high Index 01 SuspICIOn IS necessarv to 
make an early diagnosIs. I)ecause everv one 01 these disor-
Jers IS a disease Of ovenmmunosuppresslOn. patients at risk 
are those heavllv treated ior repeated episodes 01 re.leclIon. 
L'ric acid level. immunoglobulin electrophoresIs. CT scan. 
and lymph node and/Or liver biopsy <He the usual means 
to establish the diagnOSIs. Histolo\!lcaliv. the disorder can 
be mono- or poivcional. The poivclonal type tends to have a 
more benign course. 
Treatment consists In temnorarv reduction or suspension 
of Immunosuppression ano administration 01 acvclovlr. The 
response to therapy usuallv can De seen Within a lew Jays. In 
the case 01 gastrointestinal Involvement. there IS an unusu-
ally high inCidence Of small bowel penoratlOn dunng the 
REFERENCES 
Starzl TE. ~larchlor() 1'1., \l)n Kaulla K;o.;, d ;11: Homotransplan-
tatIOn 01 the Itver In humans, :>uro (,uIlec()i Ohslel 1.%.'1: II;: 
".19-7Ii, 
" Starzl TF.. Groth CC. Brettschneluer I., d al: UrthotoPlc homo-
transplantatIOn 01 the human liver. Ann .~uro 1.%'11:16'11::192-41.5, 
:1. Stanl TE. Ishikawa ,v\. Putnam C\\'. d at: Pro~ress In and deter-
rents to orthotopIC liver tranSPlantation, With speCial relerence 
to survival. resistance to hVfleracute relectlon anu biliarv duct 
reconstruction. Trunsoianl frnc I.',; 1:1'-: 1 :!Y-:lY, 
't. Borel JF. Feurer C, Cuhler Ill', d ai: tlioloilical elleets 01 cvclo-
,pOrin A: new antilvmphocvtic a~"nt, .t<Jenls ,-ict/()ns IY71i:6': 
Ifill-75, 
" (alne I{Y, Rolles K. White !J"!. d al: C,'cloSflOrIn A ,,"tlallv as 
the onlv Immunosuppressant In J-l reCIpients 01 cadavenc orllans: 
3~ kidnevs, 2 pancreases. anu 2 livers. Luncel lYi'9:2:lU3:J-.'I6'. 
h. Stanl TE, Klintmalm l;tlG. Porter KA. d ai: Liver transplantatIOn 
With use 01 cvclosporIn A and prednisone. ,\ Enol) .lled 1981: 
:;05:26'6-9. 
- Starzl TF.. Hakala TIt Shaw m\' Jr dol: ,\ Ilexlble nrocedure lor 
multiple caoaverIC or~an procurement. ,~uru Lllllecol (}hslel 
19114:1511:223-3(), 
, Benlchou J. Hall!nmson CC, lI'ed I{ III. d al: (an Inc and human 
liver preservation lor ti to I~ hr bv (OIU IOIUSlun, rr<1nSOIUnlailOn 
1!i77:24:4U7-11. 
q Starzl TE, Iwatsukl S. Es~ulvel cu, d al: l{ellOements In the sur-
gical technIque 01 liver transnlantatlOn, .~emm Lllw l!is 1911,5:5: 
i·JY-56. 
to, Iwatsukl S, Starzl TF., TuJo :i. d al: Experience In LII[)[) liver 
transplants unuer cvciusporlne-sterOid therapv: a survival report. 
Trunsplant Pmc lYIIII:20:49/'1-504. 
II. EASL: ;o.;atlonal Institutes 01 Health ("nsensus lJevelopment 
lunrerence :,tatement: Liver Transplantatlun. JUlle 2U-2:1. 19M3. 
Ifepatolool/ 19114:411 l:lU7S-I!)S. 
12. Shaw BW Jr, Wood HP, Curdon Kt), et al: Inlluence ul selected 
raBent varIables and operative blood loss on SIX' month survival 
:()llowlO~ liver transplantation . .'l<'mm Lwer VIS 1!J85:5:385-9, 
Ll. ~larkus tiH, Dickson 1':1{, Cramosch P~. et aJ: r:llicacv 01 I,wr 
transplantation 10 patients With prlmarv hil,arv ClrrnaSIS. ,\ Ellol 
) .lled 19H9:320:/i'09-J.'i. 
t-l. Malatack JJ, Sehald D), Ltbach AH. d al: ChOOSlO1l a pediatrIC 
reCipient lor orthotoplcJlver transplantation, Part II. :\ UnIvanate 
early remission period. probablv due to lysis 01 tumoral 
masses in the intestinal wall. Incidental small bowel Dost-
transplant Iymphoproliferattye disorders can be resected. 
Immunosuppression can be rernstituted or rncreased agarn 
once the disorder IS rn remission. 
OSTEODYSTROPHY 
This may be due to preexistrng disease le,g .. primary biliarv 
clrrhosis'J) and/or sterOid admrnistratlOn. Patholo~lc trac-
tures. particularly 01 the vertebrae. can be seen. High doses 
Of calcium and vitamrn [), can be admrnistered. although 
theIr eliectiveness IS debatable. 
OBESITY 
This is due to rncreased calonc intake. secondary to steroid 
administratton and general improvement rn Qualitv 01 life. 
Attentive diet control IS IreQuentlv necessarv to prevent the 
Side effects 01 obesity. 
jnd multivariate analvsls 01 pre·transplantatlOn risk lactors, 
} Pedialr IY1I7:1 110479-119, 
15. Kan~ YG, Cclman S: Liver transplantation. In t;dman S 'edl: 
tnesthes/U and (}roun TrunsO/<JnlatlOn. Philadelphia: \IB 
-;aunders. 19H7, 139-H5. 
Iii, Aldrete JA, Clapp HW. Starzl TE: Bodv temperature cnan~es 
Jurtnl! or~an transplantation, .!neslh Anul<J JY;O:49:31i4-Ii, 
I;, Lindop I'J), Farman JV. Smith j\lF: ,\nesthesla: assessment and 
IOtraoperatlve manallement. In (Jlne Hi' I"Jt: LIl'er Transpi<Jn· 
,'allOn, Lonllon: l;rune &. Stratton. I "':l. I c 1-~5. 
I~. Iwatsukl S. Slieber AC, ,'larsh J\\', et al: I, ,,'a transplantation 
1M rulmlnant hepatiC lailure. framo/unl Fro(' 191iY:211 I, hk III: 
~'J31-4, 
PI, Kanl! yt;, ~lartm OJ, ~1arquez J, et al: Intraoperative chanQes In 
hlood coa\!ulatlOn anu thromboelastol!rapmc monltortn!! In liver 
"ansplantatlOn. Aneslh AnulQ IYII.'i:64:111111-9h'. 
cO, Kanl! YG. LeWIS JH, NavalQund A: Epsilon·amlnocaprolc aCid lor 
treatment oilibrinolvsls ounn~ Itver transplantation, .-lnesthe-
,10/001/ /YII7.Bfi:i'26-3.'i. 
cL Sassano JJ: The rapid InlUSlOn system, In 1l',nter p~, KanQ IC 
leOSI: Heoallc TrunsoluntallOn: Aneslhellc und Per/OTJerulll'e 
,Ifanaoemenl. ~ew York: Prae~er ~C1entItIC, 1,)H6, 120-:l4, 
2~. ~lunson I-:S, ~Iernck HC: Effect 01 nitrous OXide on venous air 
embolism. ,-iTleSlheslO/OQ,1I 196'6':27:783-1i 
2:l, E~er 1-:1 II: The pharmacolU!lY 01 Isollurane. lir) Anaeslh IYIi4: 
ili:71S-9YS, 
21. Shanks CA. Avram MJ, Ronal AK, et al: Loss 01 tubocurarme Wllh 
~he washlnQ 01 saiva~ed autolollous niooLi ,ahstr.1. AnesiheslOlouu 
1984:61:.-1316'. 
25, Borland D1. Roule M, Cook OR: AnestheSia lor fledlatnc ortho-
'''PIC liver transplantation labstr.1. Aneslh ,·Inalu IYII5:64:1 17-:!4. 
eli. ~lazza!erro V, ESqUivel CO, ~lakowka L, d al: Factors responSible 
'"r hepatiC arterv thrombOSIS atter peulatnc liver transplantation, 
Transoianl Proc 1 YII9:2111J::!46'b'-; 
27. ~lak()wka 1" Curoon I{O. Touo S. d al: ,\l1aIVSIS 01 donor crltena 
'or the preulctlUn 01 outcome III clinical liver transplantatIOn, 
rrunso/anl I'mc 1 !J1i7: 191 J 1::1378-8:1. 
:.:~. Teperman L, Pooesta L. ,Vlleles L. d al: The successlul use 01 older 
Jonors lor Itver transplantation I letter to the eOltor!. )A.IIA IYII9: 
_'1i2:2837. 
2~. Prulm J. van Woerden \\'F. Knol E, ct al: Donor data on liver 
ORTHOTOPIC LIVER TRANSPLANTATION 7.49 
graits with primary non-function-a preliminary analysis by the 
European Liver Registry. TrartS1Jlant fmc 1989:21:2383-4. 
30. Starzl TE. ;'Iiller C. Brozmck B. et al: An Improyed techmque for 
multiple organ harvesting. Surg Gynecol Obstet 1987:165:343-8. 
31. Miller C. Mazzaferro V. Makowka L. et al: Rapid flush technique 
for donor hepatectomy: safety and elficacv of an improved method 
of liver recovery for transplantation. Transplant Pme 1988:20: 
948-50. 
32. Griffith BP. Shaw BW Jr. Hardesty RL. et al: Veno-venous bypass 
without svstemlC antlcoa!!ulation ror transolantatlon of the 
human liv~r. Surg G!lnecol Obstet 1985:160:270-2. 
33. Denmark SW. Shaw BW Jr. Starzl TE. et al: Veno-venous bvpass 
without systemrc antrcoajlulatlon In canine and human liver 
transplantatron. Surg Forum 1983:34:380-2. 
l·\' Shaw BW Jr. Martin DJ. Marquez JM. et al: AdvantalOles 01 venous 
bypass dunn!! orthotopIC transplantation 01 the liver. Semm Liver 
Dis 1985:5:344-8. 
35. Stieber AC: Hepatic transplantatIOn with the aid of the "Iron 
Intern'" retractor. Am lSurg I In preSSI. 
36. Stieber AC. Marsh JW. Starzl TE: Preservation or the retrohepatic 
vena cava dunn!! recIpient hepatectomv lor orthotoPIc trans-
plantatIOn 01 the liver. Surq Gynecol U/}stet 1989:168:542-4. 
:Ii. Starzl TE. Iwatsukl S. Shaw BW Jr: A !!rowth factor m fine vascu-
lar anastomoses. Surq G!lneeol Obstet /984:159:164-.'1. 
38. Stieber AC. AmbroSinO G. Kahn O. d al: An unusual complicatIOn 
01 choledochocholedochostomv In orthotopIC liver transplan-
tatIOn. TrartS1Jlant Pme 1988:20:619-21. 
:l9. Shaw BW Jr. lwatsukl S. Bron K. et al: Portal vein ~ralts in hep-
atic transplantatIOn. Surg Gyneeol Obstet /985:16/:66-8. 
~O. Tzakis AG. Todo S. Stieber AC. d al: Venous Jump ~ralts tor liver 
transplantation in patients with portal vein thrombOSIS. Trans-
plantation 1989:48:530-1. 
~ 1. Shaw BW Jr. Iwatsuki S. Starzl TE: Alternative methods of arteri-
alization or the hepatiC !!ralt. Surg Cyneco/ Ubstet /984:159: 
490-3. 
,\2. Tzakis AG. Todo S. Starzl TE: The anterior route tor artenal ~rait 
(onduits In liver transplantation !letter to the editOr!. Transf)/ant 
ITlt 1989:2:121. 
.\3. Waddell WH. Grover FL: The !!allbladder as a conduit between the 
liver and the intestme. Surgery 1973.14:524-9. 
,\4. ESQUIvel CO. Koneru B. Karrer F. et al: Liver transplantation 
before I year ot a~e. J Pediatr 1987:110:545-8. 
~5. Starzl TE. ESQUivel CO: Liver transplantation lor billarv atresia. 
In Glassman J ledl: Biliar!l Surqery. New York: McGraw-HilI. 
1987.61-8. 
~6. De Hemptlnne B. Salizzonl M. Tan KC. et al: The technique of 
liver Size reduction m orthotopIC liver transplantation. Transplant 
Proc 1988.-20(}. suppl 1 ):508-11. 
~i. Mazzaierro V. ESQUivel CO. Makowka L. et al: HepatiC arterv 
thrombOSIS alter pediatrIC liver transplantation-a medical or 
sur!!lcal event? TrQrtS1Jlantation 1989:47:971-7. 
~8. Starzi TE: IntroductIOn. TrGrtS1Jlanl Proc 1990:22f I. suppl 11:5. 
49. Monden M. Gotoh M. Kanal T. et al: A potent Immunosuppressive 
dfed 01 FK 506 in orthotOPIC liver transplantation m primates. 
TrGrtS1Jlant Proc 1990:22f 1. suppl 11:66-73. 
50. Ueda Y. Todo S. Eiras ~. et al: Induction 01 graft acceptance alter 
JO!! kidney or liver transplantation. Transplant Proe 1990:22 
II. suppI1J:80-2. 
51. Imventarza O. Todo S. Eiras G. et al: Renal transplantatIOn In 
baboons under FK 506. Transplant Proc 1990:22f I. supplll:64-5. 
52. Todo S. Fun~ JJ. Demetns AJ. et al: Earlv trials With FK 506 as 
pnmarv treatment Ifl liver transplantatIOn. TrGrtS1Jlant Proc 1990: 
:!2f1. suppi 11:13-6. 
53. Kav JE. Moore AL. Doe SEA. et al: The mechanism ot action ot 
FK 506. TrQrtS1Jianl Proc 1 990:22(}. supplll:96-9. 
54. Moms RE. Wu J. Shorthouse R: Comparative Immunopharmaco-
logic ellects of FK 506 and CvA Ifl Ifl VIVO models oi or~an trans-
7.50 ATlAS OF ORGAN TRANSPlANTATION 
plantation. TrQrtS1Jlant Proc 1990:22f I. suppi 1):110-3. 
55. Jain AB. Fun~ JJ. Venkataramanan R. et al: FK 506 dosage in 
human organ transplantation. Transp/anl Pree 1990:22fI. suppl 
[):23-4. 
56. Fung JJ. Todo S. Jain AB. et al: Conversion from cyciosporine to 
FK 506 in liver allo!!ratt reCipients With cyclosporme-related 
complications. TrartS1Jiant Proc 1990:22f I. sUrJpi 11:6-12. 
57. Shapiro R. Fun!! JJ. Bain AB. et al: The side effects 01 FK 506 in 
humans. Transplant fmc 1990:22fl. sUf)pl1 1:35-6. 
58. McCauley J. Fung J. Jain A. et al: The etfects 01 FK 506 on renal 
function after liver transplantatIOn. Transplant Pree 1990:22 
1/. sUPrJI11:17-20. 
59. AlesSl3n1 M. Kusne S. !>lartin I'M. et al: Infections With FK 506 
immunosuppression: prellminarv results With pnmary therapy. 
Transplant Pree 1990:22fI. supplll:44-h'. 
tiO. Yanalla K. Starzl TE: Cardiac arrest In brain-dead organ donors. 
lAMA (in press'. 
hI. Todo S. Nery J. Yanal'1a K. et al: Extended preservatIOn oi human 
liver grafts With UW solution. lAHA 1989:261:711-4. 
62. Cuervas-Mons V. Martinez AJ. Dekker A. et al: Adult liver trans-
plantation: an analYSIS 01 the earlv causes ot death in 40 consecu-
tive cases. Hepaloloq!l1986:6:495-S01. 
63. Iwatsuki S. Rabin BS. Shaw BW Jr. et al: Liver transplantation 
against T cell-pOSItive warm cross matches. Transplant Pree 1984; 
16:1427-9. 
04. Gordon RD. Iwatsuki S. EsqUivel CO. et al: Liver transplantation 
across ABO blood Ilroups. Surqerq /986:/00:342-8. 
tiS. Starzl TE. Tzakls AG. ~Iakowka l..: The definitIOn 01 ABO factors 
In transplantation: relation to other humoral antibody states. 
Transplant Pree 1987:19:4492-7. 
ti6. Starzl TE. Demetns AJ. Todo S. et al: Evidence lor hvperacute 
rejection of human liver I'1ralts: the case or the canary kidneys. 
Clin TrartS1Jlantation 1989:3:37-45. 
tii. Moore SB. Wiesner HH. PerkinS JD. et al: A pOSitive Ivmphocyte 
crossmatch and major hlstocompatlbilitv complex mlsmatchin!! 
Jo not predict early rejection ot liver transplants in patients 
treated With cvciosponne. Trunsplanl Pme 1987;19:2390-1. 
68. Bird G. Friend P. Donaldson P. et al: Hyperacute re,ectlOn In liver 
transplantation: a case report. Transplant Proe 1989:21:3742-4 . 
69. ESQUIVel CO. Jaffe R. Gordon RD. et al: Liver rejectIOn and its dlf-
ierentlation trom other causes 01 Ilralt dysfunction. Semm Liver 
Dis 1985:5:369-74. 
iO. Starzl TE. DemetrlS AJ. Van Thiel DH: Medical pro!!ress: liver 
transplantation. N Enql 1 Ned 1989:321:1014-22. 
il. Tzakis AG. Gordon RD. Shaw BW Jr. et al: Clinical presentallon 01 
hepatiC artery thrombOSIS alter liver transplantatIOn in the 
(yclosporme era. TransrJlantatwn 1986:40:66'7-71. 
n. Zajko AB. Bron KM. Starzl TE. et al: An!!lography of liver trans-
plantatIOn patients. Radioloq!l1985:157:305-11. 
i3. Lerut J. Gordon RD. Iwatsukl S. et al: Biliary tract complications 
In human orthotopIC liver transplantation. TrartS1Jlantation 1987: 
.J3:47-50. 
i 4. Zajko AB. Bron KM. Campbell WL et al: Percutaneous transhep-
atlc cholan!!iography and biliary dramalle alter liver transplanta-
tion: a live-year expenence. Custromtest Radiol 1987:12:137-43. 
is. Koneru B. Tzakls AG. Bowman J III. et al: Postoperative sur!!lcal 
(omplicallons. Custroentero/ c/in North Am 1988:17:71-91. 
i6. Ferl!uson RM. Sommer BG: Cvciosporme m renaltransplanta-
tlon: a smilie institutIOnal experience. Am 1 Kidne!/ Dis 1985;5: 
:!96-306. 
Ii. Keown PA. Stiller CR. Wallace AC: NephrotOXICity of cvciosporm 
.\. in Williams GM. Burdick JF. Solez K ledsl: Kidne!l Transplant 
Rejection. New York: Dekker. 1986. 423-Si. 
78. Solez K. McGraw DJ. Beschorner WE. et al: Reflections on use of 
the renal biopsy as the "!!old standard" in distmgulsh,"!! trans-
plant rejection trom cvciosponne nepnrotoxlClty. TrQrtS1Jiant Proe 
1985:1714. supp/1):123-33. 
i9. Klintmalm GBG. Bohman SO. Sunde lin B. et al: Interstitial fibro-
sis in renal allografts after 12 to 46 months of cyciosporine treat-
ment: beneficial effect of low doses in early post·transplant penod. 
Lancet 1984;2:950-4. 
80. Klintmalm GBG. Iwatsuki S. StaTZI TE: Cyclosponn A hepatotoxI-
city in 66 renal allograft reCIpients. TransplantatIOn 1981:32: 
488-9. 
81. Shah D. Rylance PB. Rogerson ME. et al: Generalised epileptic 
fits in renal transplant recIpients given cvclosponn A (short 
report). Br Med J 1984:289:1347-8. 
82. Kahan BD: Cyclosponne: the agent and its actions. in Kahan BD 
led): Cyclosporine. New York: Grune &: Stratton. 1985.5-18, 
83. Jarowenko MV. Flechner SM. Van Buren CT. et al: Influence of 
cvciosponne on posttransplant blood pressure response. Am J 
Kidney Dis 1987: 10:98-103. 
H4. Thompson ME. Shapiro AP. Johnsen AM. et al: New onset of 
hypertension followin~ cardiac transplantatIOn: a preliminary 
report and analysIs. Transplant Proc 1983:15(4. suppl 1):2573-7. 
~5. Adu D. Turney J. ~Iichael J. et al: Hvperkalemia In cyclosponn-
treated renal allogratt recipients. Lancet 1983:2:370-1. 
,~6. European Multicentre Trial Group. Cyclosponn In cadaveric renal 
transplantatIOn: one year follow-up ot a multlcentre tnal. Lancet 
1983:2:986-9. 
87. Bennett WM. Norman DJ: Action and toxicity of cyclosporine. 
Annu Rev Med 1986:37:215-24. 
88. Stieber AC. AmbrOSinO G. Van Thiel DH. et al: Orthotopic liver 
transplantation for fulminant and subacute hepatiC failure. 
Gastmenteral c/in North Am 1988:17:157-65. 
89. Amer P. Gunnarsson R. Blomdahl S. et al: Some characteristics oi 
steroid diabetes: a study in renal·transplant recipients receiVing 
high-dose corticosteroid therapy. Diabetes Care 1983:6(1):23-5. 
90. Fennell RS. Van Deusen J. Riley WJL: Steroid· induced diabetes In 
pediatric renal transplant reclpients.lnt J Pediatr Nephral 1983: 
4121:103-7. 
91. Gimenez LF. Watson AJ. Burrow CR. et al: De novo diabetic 
nephropathy With functional impairment In a renal allograit. Am 
J Nephral 1986:6:378-8/. 
92. Makowka L. Nalesnik M. Stieber A. et al: Control of post-trans-
plant lymphoproliferative disorders and Kaposl's sarcoma by mod-
ulation of immunosuppression. In Good RA led): The Nature. 
Cellular and Biochemical Basis and Manaqement of Immuno-
deficiencies. Stuttgartt. New York: fK Schattauer Verlag, 567-618. 
93. Weaver GZ. Frank WA. Streck WF. et al: Hepatic osteodystrophy 
.iter liver transplantation In patients With pnmary biliary cirrho-
sis. Am J Gastmenteral 1983:78:102-60. 
ORTHOTOPIC LIVER TRANSPLANTATION 7.51 
